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ABSTRACT 
 
Cyclic guanosine monophosphate (cGMP) is a second messenger that plays an 
important role in many cell types of the retina. It is involved in a variety of 
intracellular signaling processes mostly by activating protein kinases or by binding to 
ion channels. In photoreceptors, cGMP is crucially involved in visual signal 
transduction. In many neurons of the inner retina, cGMP is synthesized by soluble 
guanylate cyclases (sGC) upon activation by nitric oxide (NO). So far, there is no 
common view of the contribution of cGMP to retinal adaptation or to the modulation 
of signaling processes in other retinal cell types, although many attempts to 
investigate those processes have been made in the past. 
Using stimulation of the retina with the nitric oxide donor SNAP followed by 
immunohistochemistry with an antibody against cGMP, I could demonstrate cGMP 
synthesis controlled by NO in a variety of cell types of the intact mouse retina. 
However, this method does not enable to resolve the dynamics of this process. I, 
therefore, aimed at the expression of the FRET-based genetically encoded cGMP 
sensor Cygnet-2.1 in retinal cultures and in the intact retina to monitor the production 
of cGMP in real time using imaging techniques.  
In control experiments I expressed Cygnet-2.1 functionally using the lipofectamine 
transfection in FlpTS GC-A cells (derived from HEK-293 cells) that served as model 
system. In these cells the synthesis and degradation of intracellular cGMP could be 
monitored upon activation of membrane-bound guanylate cyclases with atrial 
natriuretic peptide (ANP). The next aim was to establish Cygnet-2.1 expression in 
retinal cells. To this end, retinal cultures were established and seven different AAV 
serotypes encoding GFP were screened for their transduction efficiency in this in vitro 
model. AAV2 was selected as the most promising vector based on its wide range of 
transduction patterns among the retinal cell types and the high transduction efficiency. 
In the next step, AAV-mediated transduction was established in vivo. AAVs were 
delivered via ocular injection to newborn mice. Again, AAV2 was determined as the 
most promising candidate for transduction of retinal neurons. Finally, Cygnet-2.1 
sensors were expressed in dissociated retinal cultures by using lipofectamine 
transfection and AAV-mediated transduction. Using lipofectamine transfection, 
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changes in Cygnet-2.1 fluorescence revealed a fast increase in the internal cGMP 
concentration upon NO stimulation in cultured retinal neurons that were 
immunoreactive for sGC. Upon AAV2-mediated transduction, no change in the 
Cygnet-2.1 fluorescence could be detected in retinal cells upon stimulation with NO 
donors or in the FlpTS GC-A cells upon stimulation with ANP. Most likely, AAV-
mediated transduction did not yield functional Cygnet-2.1 sensors. Nevertheless, the 
proof of principle experiments clearly demonstrated that it is possible to investigate 
cGMP metabolism in the retina under physiological conditions using Cygnet-2.1. In 
future, the established methods in this thesis can drive the investigation of cGMP 
modulation in vivo and in vitro by means of optogenetic approaches and, thereby, 
foster our understanding of retinal adaptation and signal modulation.  
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ZUSAMMENFASSUNG 
 
Zyklisches Guanosinmonophosphat (cGMP) ist ein sekundärer Botenstoff, der in 
vielen retinalen Zelltypen eine wichtige Rolle spielt. cGMP ist an einer Reihe 
verschiedener intrazellulärer Signalverarbeitungsprozesse beteiligt indem es 
Proteinkinasen aktiviert oder an Ionenkanäle bindet. In den Photorezeptoren ist cGMP 
entscheidend an der visuellen Signalweiterleitung beteiligt. Viele Neurone der inneren 
Retina synthetisieren cGMP mit Hilfe einer durch Stickoxid (NO) aktivierten 
löslichen Guanylatzyklase (sGC). Trotz zahlreicher Untersuchungen ist bisher nicht 
vollkommen geklärt, wie cGMP zum Prozess der retinalen Adaptation beiträgt oder 
die Signalverarbeitung in den unterschiedlichen retinalen Zelltypen moduliert. 
Nach Stimulation der Retina mit dem NO-Donor SNAP und anschließender 
Immunhistochemie mit einem Antikörper gegen cGMP konnte ich zeigen, dass NO 
die Synthese von cGMP in einer Reihe unterschiedlicher Zelltypen bewirkt. Die 
Methode ermöglicht es aber nicht, die Dynamik der cGMP Synthese im retinalen 
Netzwerk zu untersuchen. Das Ziel der Arbeit war es deshalb, den genetisch codierten 
FRET basierten cGMP Sensor Cygnet-2.1 in retinalen Zellkulturen und in der intakten 
Retina zu exprimieren. Diese Methode ermöglicht es mittels Imagingtechnik die 
Synthese von cGMP in Echtzeit zu verfolgen. 
Zunächst exprimierte ich Cygnet-2.1 in FlpTS GC-A-Zellen, die als Modellsystem 
dienten (abgeleitet aus HEK293-Zellen). Hier konnte ich die Synthese und den Abbau 
von intrazellulärem cGMP nach Aktivierung von membranständigen 
Guanylatzyklasen durch das atriale natiuretische Peptid (ANP) verfolgen. In einem 
nächsten Schritt sollte Cygnet-2.1 in retinalen Zellen exprimiert werden. Hierzu habe 
ich retinale Kulturen etabliert und anschließend in diesem in vitro Modellsystem die 
Transduktionseffizienz von sieben verschiedenen GFP exprimierenden AAV 
Serotypen überprüft. AAV2 war hier der vielversprechendste Vektor, da er in allen 
retinalen Zellklassen zu einer starken Expression führte. In einem nächsten Schritt 
habe ich die AAV-gestützte Transduktion in vivo etabliert. Die AAVs wurden hierzu 
in die Augen neugeborener Mäuse injiziert. Auch in diesem Fall schien AAV2 der 
erfolgversprechendste Vektor zu sein.  
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Im Anschluss habe ich Cygnet-2.1 in retinalen Dissoziatkulturen sowohl mittels 
Lipofectamintransfektion als auch mit Hilfe der AAV vermittelten Transduktion 
exprimiert. Nach Transfektion mit Lipofectamin und Stimulation mit NO Donoren 
konnte durch Änderungen der Cygnet-2.1 Fluoreszenz ein schneller Anstieg der 
internen cGMP Konzentration in retinalen Neuronen, die lösliche GC exprimierten, 
nachgewiesen werden. Nach AAV vermittelter Transducktion waren dagegen keine 
Änderungen in der Cygnet-2.1 Fluoreszenz in retinalen Zellen nach Stimulation mit 
NO Donoren oder in FlpTS GC-A-Zellen nach Zugabe von ANP erkennbar. Die 
Vermutung liegt nahe, dass die AAV vermittelte Transduktion zu nicht-funktionellen 
Cygnet-2.1 Sensoren führte. Nichtsdestoweniger konnten die Machbarkeitsstudien 
dieser Arbeit deutlich zeigen, dass grundsätzlich die Möglichkeit besteht, den 
Metabolismus von retinalem cGMP unter physiologischen Bedingungen mit Hilfe von 
Cygnet-2.1 zu untersuchen. 
Die hier etablierten Methoden können in Zukunft weiterführende, optogenetische 
Untersuchungen zur Modulation von cGMP sowohl in vitro als auch in vivo 
ermöglichen und so unser Verständnis der retinalen Adaptation und Modulation 
voranbringen. 
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1. INTRODUCTION 
The mammalian retina is a light sensitive tissue lining the inner surface in the 
posterior portion of the eye. During embryonic development, the retina and the optic 
nerve originate from the developing brain, therefore, the retina is considered as part of 
the central nervous system (CNS). There are several features that make the 
mammalian retina particularly attractive for scientific research. Most importantly, 
unlike the rest of the CNS, the retina is unusually suitable to be studied intact in vitro. 
Although its thickness is just about several hundred μm (no more than 200 μm in 
mouse), the retina remains intact when being separated from surrounding tissues 
except that the optic nerve has to be cut. The retina can be kept alive for several hours 
when incubated in oxygenized physiological solutions. In vitro, physiological 
investigations like imaging or patch clamp can be performed. Therefore, the retina is a 
very suitable model of the central nervous system for neurophysiological or 
neurochemical studies.  
Mice are the most commonly used vertebrate species due to their suitable size, low 
cost and quick reproduction rate. They are considered to be a good experimental 
model. Most importantly, taking the advantages of genetic technology, gene 
modification in mice is possible; therefore, mice or their organs can be genetically 
modified. Most commonly used techniques encompass knock-out or knock-in of 
genes or expression of reporter genes or cellular markers.  
All in all, the mouse retina is an ideal model of the mammalian CNS in the research 
fields of neurobiology and neurophysiology.  
 
1.1 Retina and phototransduction 
Intuitively one could expect that the front surface of the retina harbors the light 
sensing cells, the photoreceptors; however, in the vertebrate retina these cells are 
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located at the opposite side. This means that light has to pass through the entire retina 
with its different layers of neurons before it reaches the outer segments of 
photoreceptors where visual pigments are found (Figure 1.1). There are two kinds of 
photoreceptors in the retina: rods and cones. In humans, rod density decreases close to 
the fovea, whereas cone density peaks in the fovea (Osterberg, 1935; Curcio et al., 
1990). Rods are very sensitive to light and are capable of detecting single photons. 
They are specialized for scotopic vision. Cones are less sensitive, but faster due to 
their short response time to stimuli (Kandel et al., 2000). The cone system provides us 
with good resolution and the perception of color. In humans, there are three types of 
cones with different opsins, having absorption maxima at different wavelengths 
(Jameson et al., 2001; Purves et al., 2001). Hence, cones are responsible for photopic 
and color vision. The photoreceptor cell bodies form the outer nuclear layer (ONL).  
In the absence of light, both rods and cones are depolarized and release glutamate as 
transmitter at their synapses. A key second messenger molecule that maintains the 
cells in their depolarized state is cyclic guanosine monophosphate (cGMP). (As 
cGMP is of special interest in this thesis, detailed information will be given in Chapter 
1.3.) A high concentration of cGMP in the photoreceptor outer segment keeps 
cGMP-gated ion channels open and causes an inward current carried mainly by 
sodium ions that leads to depolarization of the cell. Upon illumination, photons are 
captured by opsins in the outer segments of photoreceptors and the opsins become 
activated. The activated opsins unlock the activity of phosphodiesterases (PDEs) via 
G-proteins. As a consequence, PDEs can hydrolyze cGMP, thereby reducing its 
intracellular concentration. The decrease of the cGMP level causes the closing of 
cGMP-gated ion channels, which leads to the hyperpolarization of the photoreceptors. 
Subsequently, glutamate release ceases (reviewed by Müller and Kaupp, 1998). The 
changes in neurotransmitter release are registered by bipolar cells and horizontal cells 
in the first synaptic layer, the outer plexiform layer (OPL). Bipolar cells relay the 
information to the inner plexiform layer (IPL) where they are connected to retinal 
ganglion cells (GCs) and amacrine cells (ACs). The ganglion cells are the retinal 
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output neurons that transmit the visual signals to the brain through the optic nerve. 
 
Figure 1.1: Cellular organization of the retina.  
A: Schematic drawing of a vertical section through the mammalian retina ca. 1900 by Santiago 
Ramon y Cajal. The scheme is based on observations of cells impregnated by the Golgi method. In 
the picture, the cell types are marked: rods and cone; HC, horizontal cell; BC, bipolar cell; AC, 
amacrine cell; GC, ganglion cell; MC, Müller cell. The following layers are shown: OS, outer 
segments; IS, inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner 
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NFL, nerve fiber layer. 
Arrows represent the direction of light passing through the retina.  
B: Differential Interference Contrast (DIC) image of a vertical section through the mouse retina.  
Scale bar = 20 μm. 
 
The transmission of visual information from photoreceptors to ganglion cells is not 
just a relay race. At every synaptic connection, the information is further processed. 
Basically, there are two pathways after the first synaptic relay in the OPL: the ON- 
and the OFF-pathway. While all photoreceptors are hyperpolarized during 
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illumination, two groups of bipolar cells behave in opposite ways. Their response is 
determined by two different glutamate receptors at their dendrites. OFF-bipolar cells 
have ionotropic glutamate receptors and, therefore, follow the behavior of 
photoreceptors. They are depolarized in the dark, but hyperpolarized upon 
illumination when glutamate release from photoreceptors ceases. ON-bipolar cells are 
depolarized or activated during illumination. In the light, cation channels in 
ON-bipolar cells, most likely the TRPM1 channels (Morgans et al., 2009), are open 
leading to a depolarizing ion flux. In the dark, glutamate acting at metabotropic 
glutamate receptors at the ON-bipolar cell dendritic tips leads to the activation of 
G-Proteins followed by the closing of the cation channels and, hence, 
hyperpolarization of the cell (Slaughter and Miller, 1981; Nawy and Jahr, 1990, 1991; 
Yamashita and Wässle, 1991). The ON/OFF dichotomy is preserved in the subsequent 
stages of the visual system. The processing of visual signals is affected by extending 
processes from horizontal cells in the OPL and from amacrine cells in the IPL. These 
connections are called lateral pathways. Horizontal cells extend long lateral processes 
and collect signals from distant photoreceptors. They modulate the output signals 
from photoreceptors via lateral inhibition and are, therefore, important for the 
generation of antagonistic receptive fields. In the IPL, light responses are strongly 
modulated by amacrine cells providing feedback inhibitory input to bipolar cells, or 
lateral inhibitory input to other amacrine cells and ganglion cells. To this end, there 
are various types of amacrine cells with different functions. In the end, a ganglion cell 
may transmit visual information which is quite complex, but best described by the 
properties of the cells receptive field.   
 
1.2 Bipolar cells and Amacrine cells 
Bipolar cells and amacrine cells are the main retinal neurons involved in the nitric 
oxide (NO)-cGMP pathway, which will be introduced in Chapter 1.3. Thus, more 
information about these two retinal cell classes will be provided in the following.  
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Bipolar cells received their name from the fact that two processes arise from their 
soma. They work as bridges connecting the two plexiform layers. Usually, bipolar cell 
bodies are located in the outer half of the INL. Their dendrites synapse with 
photoreceptors and horizontal cells in the OPL to collect the visual information. The 
information is relayed via their axon and passed on to ganglion cells at the bipolar cell 
axon terminal. Bipolar cells propagate signals via graded potentials instead of action 
potentials. The axons of different bipolar cells branch at different levels of the IPL 
(described by Cajal, 1892) where processes of different types of amacrine cells and 
ganglion cells ramify. ON-bipolar cells terminate in the inner half part of the IPL 
close to the GCL, while OFF-bipolar cells terminate in the outer half. Within the ON- 
or OFF-sublayers, axons of different bipolar cell types terminate at different levels, 
suggesting that they contact different postsynaptic partners (Boycott and Wässle, 
1991). Based on this morphological criteria, in the mammalian retina bipolar cells are 
subdivided into 9 ~ 12 different types (reviewed by Masland, 2001). In mouse retina, 
11 types of cone bipolar cells and 1 type of rod bipolar cell have been classified 
(Ghosh et al., 2004; Wässle et al., 2009). Each type of bipolar cell shows a 
characteristic cell number per unit area as well as characteristic sets of 
neurotransmitter receptors and signaling proteins. Figure 1.2 shows a schematic 
diagram of bipolar cells of the mouse retina. The IPL is subdivided into 5 sublaminae. 
The level of stratification of bipolar cell axon terminals in the IPL is the major 
criterion for bipolar cell classification. Furthermore, specific immunomarkers and 
transgenic mouse lines that express markers in certain bipolar cell types can be used 
to identify bipolar cells. Until now, classification of bipolar cells is most likely 
complete (Wässle et al., 2009). It greatly helps to functionally understand the bipolar 
cells and their role within the circuitry of the retina.  
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Figure 1.2: Schematic diagram of bipolar cells in the mouse retina. (taken from 
Wässle et al., 2009) 
A total of 11 cone bipolar cells and 1 rod bipolar cell can be distinguished by 
immunohistochemical staining (outlines; markers given above cell type) or by GFP/Clomeleon 
expression in transgenic mouse lines (green cells). The level of stratification of bipolar cell axon 
terminals in the IPL is the major criterion for classification.  
 
Amacrine cells interact with bipolar cells and ganglion cells in the IPL and appear to 
be the most diverse class of retinal interneurons. In the mouse retina, their somata are 
localized to the two innermost cell layers of the INL, but are also found as “displaced 
amacrine cells” in the GCL. In the INL, they make up 41% of all cells (Jeon et al., 
1998). In mammals about 20 to 30 different types of amacrine cell have been 
discovered (Vaney, 1990; Wässle and Boycott, 1991; MacNeil and Masland, 1998; 
Menger et al., 1998) which are thought to have distinct dedicated functions like 
adaptation, shaping output signals from bipolar cells, controlling of ganglion cell 
responses, etc. The different amacrine cells differ considerably in their pre- and 
postsynaptic partners as well as their neurotransmitters and molecular components. 
The major subdivision is into γ-aminobutyric acidergic (GABAergic) amacrine cells 
and glycinergic amacrine cells with each representing 40% ~ 50% of the whole 
amacrine cell population in the mouse retina (Pourcho and Goebel, 1985; Marc, 1988; 
Nguyen-Legros et al., 1997; Pow and Hendrickson, 1999; Lin and Masland, 2006). In 
addition, other neuroactive substances are also found in specific amacrine cell types, 
like: tyrosine hydroxylase in dopaminergic amacrine cells, choline acetyl transferase 
in cholinergic amacrine cells, and nitric oxide synthase (NOS) in NO-releasing 
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amacrine cells.  
1.3 Cyclic guanosine monophosphate (cGMP) and the NO-cGMP pathway in the 
retina 
Since the fundamental plan of the retina has been introduced in detail, the essential 
background about the key molecule in this project “cGMP” will be provided in this 
chapter. cGMP is a cyclic nucleotide composed of a sugar residue, a nitrogenous base 
and a phosphate forming a cyclic bond (Figure. 1.3).  
 
 
Figure 1.3: 
Molecular structure of cyclic guanosine 
monophosphate (cGMP). 
 
cGMP is derived from guanosine triphosphate (GTP) in an enzymatic reaction 
catalyzed by guanylate cyclases. It was in the 1960s, together with cyclic adenosine 
monophosphate (cAMP), that cGMP was found as a natural compound (for review see 
Beavo and Brunton, 2002). Since then, cAMP was paid much attention and its 
important role as second messenger in relaying signals from receptors on the cell 
surface to the cell interior has been elucidated. Earl W. Sutherland won a Nobel Prize 
for his contributions to the formulation of the second-messenger concept in 1971. 
Consequently, cGMP was rewarded little attention, although it was considered a 
second messenger quite early in 1970. The biological function of cGMP had remained 
a mystery until two key discoveries were made in the 1980s. First, atrial natriuretic 
peptide (ANP), a peptide synthesized in the heart, was found to stimulate cGMP 
synthesis by binding to a transmembrane receptor named particulate guanylate cyclase 
(pGC). Second, a substance known to dilate blood vessels - the elusive 
endothelium-derived relaxing factor - was identified as nitric oxide, which stimulates 
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soluble guanylate cyclase (sGC) in smooth muscle cells to synthesize cGMP, thereby 
causing vasorelaxation (Feil and Kemp-Harper, 2006). For the discovery of the 
NO-cGMP pathway in the cardiovascular system, Robert F. Furchgott, Louis J. 
Ignarro and Ferid Murad were awarded the Nobel Prize in 1998. After that, interest in 
cGMP metabolism grew. Later on, other mysteries of cGMP metabolism and signal 
transduction were revealed. So far, it has been quite clear that there are two possible 
processes controlled by cGMP (reviewed by Scott, 1991): 1) cGMP acts as a second 
messenger most notably to activate cGMP-dependent protein kinase or protein kinase 
G (PKG) which in turn phosphorylates several downstream targets responsible for 
diverse functions of cGMP such as regulation of vascular tone, gastrointestinal 
function, neuronal activity, and many others (for review Hofmann et al., 2006). 2) 
cGMP also can bind to certain ion channels known as cGMP-gated channels leading 
to channel opening and causing a sodium inward current. This channel type was 
initially identified in rod photoreceptors (Kaupp et al., 1989). Inactivation of cGMP is 
possible as it is degraded to 5'-GMP by PDEs (Beavo and Reifsnyder, 1990). PDEs 
can be inhibited by a number of substances including the nonselective PDE inhibitor 
3-isobutyl-1-methylxanthine (IBMX). Interestingly, the various functions of cGMP 
are all found in visual transduction where cGMP-gated channels, PDEs and PKG are 
all involved (Maelicke, 1990). 
Therefore, the retina turns out to be a particularly suitable tissue for the investigation 
of cGMP metabolism and function. Moreover, advances in the field of cGMP 
metabolism in the retina can help to understand its respective function in the other 
parts of the CNS.  
Nitric oxide synthase (NOS), the enzyme catalyzing the generation of nitric oxide 
from L-arginine, exists in three major isoforms: neuronal, endothelial and 
immunologic NOS (reviewed by Goldstein et al., 1996). In immunohistochemical 
studies neuronal NOS (nNOS), also termed brain NOS (bNOS), was detected by 
specific antibodies in mammalian retinal neurons. It was revealed that certain types of 
amacrine cells in the rat, mouse, cat, guinea pig, and rabbit retina were consistently 
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labelled for nNOS (Kim et al., 1999); furthermore, some bipolar cells of the rat and 
guinea pig, some photoreceptors of the rabbit, and some Müller cells of the cat 
showed NOS immunoreactivity, as well (Kim et al., 1999). These results suggest that 
nitric oxide acts as a signaling molecule in retinal physiology. Since nitric oxide is a 
gaseous molecule with very short half-life, the spatial distribution of nitric oxide and 
its relationship to neuronal activity is difficult to resolve. However, detection of 
cGMP via specific antibodies in sections of retinae treated with nitric oxide-releasing 
chemicals gave insight into the NO-cGMP pathway in the retina. Blute and his 
coworkers examined turtle retina and found an increase of cGMP immunoreactivity in 
the inner retina (Blute et al., 1998). Similar results were observed in bovine retina 
(Gotzes et al., 1998), rat retina (Johansson et al., 2000), the goldfish retina (Baldridge 
and Fischer, 2001), and salamander retina (Blom et al., 2009). By using a specific 
antibody against sGC, Ding and Weinberg found that the nitric oxide receptor sGC 
was expressed in many neurons of the rat inner retina (Ding and Weinberg, 2007).  
During my previous studies, using an antibody against cGMP I have studied the 
modulation of cGMP synthesis in the mouse retina (Zhao, 2010). I found that cGMP 
levels in the inner part of the retina can be strongly modulated by NO (Figure 1.4). 
Mainly bipolar cells and amacrine cells were involved. The bipolar cells 
immunoreactive for cGMP were identified as type 3a, 3b, 5, and 7 bipolar cells. 
Therefore, the NO-cGMP pathway has been demonstrated in the mouse inner retina 
(Zhao, 2010; Blom et al., 2012).  
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Figure 1.4: Increase of cGMP-immunoreactivity (cGMP-IR) in the mouse inner 
retina by exogenous NO. (taken from Zhao, 2010) 
A: A vertical section of a mouse retina after incubation in the PDE inhibitor IBMX. Moderate 
cGMP-IR was found in the IS, weak label in the OPL and the IPL. Short arrow marks a soma of a 
photoreceptor with strong cGMP-IR. Three bipolar cells (marked by long arrows) in the INL were 
weakly positive. In the GCL, some cells (arrow heads) were also found to show cGMP-IR.  
B: A vertical section of the second retina from the same mouse incubated in the presence of the 
NO-donor SNAP and IBMX. The staining pattern in the outer retina was the same as in A. Strong 
cGMP-IR was found in the inner retina. The dendrites of bipolar cells were seen to ramify in the 
OPL (arrows). The dashed line separates the outer part and the inner part of the INL. Several 
amacrine cells (arrow heads) also showed cGMP-IR. The entire IPL (borders marked by 
horizontal lines) displayed very strong staining patterned in several bands. Enhanced cGMP-IR 
was also observed in the GCL.  
Scale bar = 20 μm. 
 
1.4 Genetically encoded FRET-based cGMP sensors 
Immunochemistry with antibodies against cGMP offers a valuable tool to study cGMP 
metabolism in an intact tissue. However, as cGMP immunohistochemistry is only 
possible after the tissue has been fixed, the results are “snapshots” and the method is 
limited mostly in neglecting the dynamic of metabolism processes. Therefore, it is 
necessary to use additional approaches that allow the investigation of cGMP with high 
temporal and spatial resolution. During the recent decades, several genetically 
encoded biosensors have been generated. They can be introduced and expressed in 
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cells in living organisms and tissues. Typically these sensors are designed in a 
stereotypical way: two fluorescent proteins are fused to a binding protein that interacts 
with the cellular compound that is to be detected. In the case of a cGMP sensor, the 
cGMP binding domain was chosen from cGMP interacting proteins such as PKG 
(Honda et al., 2001; Honda et al., 2005; Russwurm et al., 2007) or PDE2/PDE5 
(Nikolaev et al., 2006; Niino et al., 2009). The working principle of all these sensors 
is based on the Förster resonance energy transfer (FRET).  
1.4.1 Förster resonance energy transfer 
FRET is a non-radiative energy transfer between an excited donor and an acceptor 
fluorophore, which leads to specific fluorescence emission of the acceptor without its 
direct excitation (Förster, 1948). When a donor fluorophore is excited to a 
higher-energy state by incident light within its absorption spectrum, it will normally 
decay to the ground state by emitting a photon within a characteristic emission 
spectrum. If another fluorophore (the acceptor) exists in proximity (≤ 10 nm) to the 
donor and has an absorption spectrum that overlaps with the emission spectrum of the 
donor, the energy of the donor can be transferred to the acceptor causing the acceptor 
to emit fluorescence. Figure 1.5 shows the absorption and emission spectra of cyan 
fluorescent protein (CFP) and yellow fluorescent protein (YFP), which form the 
FRET pair in most FRET-based sensors. 
 
 
Figure 1.5: 
CFP (donor) and YFP (acceptor) 
absorption and emission spectra. 
Overlap between CFP emission and YFP 
absorption (shaded region) leads to efficient 
FRET interaction. 
(http://www.semrock.com/Data/Sites/1/semr
ockimages/technote_images/graph_fret_cfpy
fpoverlap.gif) 
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1.4.2 The cGMP biosensor Cygnet-2.1 
In this project, a biosensor named Cygnet-2.1 (Honda et al., 2001; Honda et al., 2005) 
was employed for real-time cGMP imaging. Cygnet-2.1 is a genetically encoded 
FRET-based cGMP sensitive protein. This biosensor is composed of three parts 
(Figure 1.6): a cGMP binding site cloned from PKG flanked by the two fluorescent 
proteins CFP and YFP. CFP is the donor, whereas YFP is the acceptor. When the 
sensor is free of cGMP, energy can be transferred from CFP to YFP due to FRET. 
Upon the binding of cGMP, a conformational change in the sensor is induced. 
Therefore, the distance between donor CFP and acceptor YFP is increased, reducing 
the FRET efficiency between the two fluorescent proteins. To read out cGMP binding, 
emission intensities of the donor and the acceptor upon donor excitation are detected, 
and the FRET signal is depicted as a ratio of donor and acceptor fluorescence. The 
incidence of FRET is inversely related to the cGMP concentration.  
 
Figure 1.6: Mechanism of the cGMP sensor Cygnet-2.1. 
Cygnet-2.1 contains a cGMP binding site (brown) and the two fluorescent proteins CFP and YFP. 
Upon the binding of cGMP, a conformational change is induced that reduces FRET efficiency 
between the two fluorescent proteins. 
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1.5 FlpTS GC-A cell line and its signalling pathway 
The FlpTS GC-A cell line can be used as a model system to test Cygnet-2.1. This cell 
line was derived from HEK-293 cells. A cGMP signaling pathway was designed 
(Figure 1.7) by co-expressing appropriate signaling proteins: the membrane-bound 
receptor guanylate cyclase-A (GC-A) and a cyclic nucleotide-gated (CNG) ion 
channel. The GC-A can be activated by application of atrial natriuretic peptide (ANP). 
Binding of ANP induces a conformational change in the receptor that causes receptor 
dimerization and activation (Wilson and Chinkers, 1995; Yang and Garbers, 1997; 
Labrecque et al., 1999) and conversion of GTP into cGMP by the GC-A, raising the 
intracellular cGMP concentration. As a consequence, the elevation of intracellular 
cGMP causes CNG channels to open. This channel is permeable to calcium; hence the 
activation of the CNG channel can easily be monitored using calcium imaging 
techniques. 
 
Figure 1.7: Signaling pathway in the FlpTS GC-A cell line. 
Upon the binding of ANP, guanylate cyclase-A is activated and synthesizes cGMP from GTP. 
cGMP activates cGMP-gated channels, allowing for the entry of calcium into the cell.  
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1.6 Adeno-associated viruses (AAV) 
To introduce the sensor protein into individual cells or living organisms in vivo, 
recombinant AAVs can be used as a gene ferry.  
Adeno-associated viruses were discovered and isolated in 1960’s. They were initially 
described as adenovirus-associated small DNA-containing particles behaving like 
defective viruses (Atchison et al., 1965, 1966). They are one of the smallest virus 
types with a non-enveloped capsid of approximately 22 nm diameter (Hoggan et al., 
1966). AAVs display very low immunogenicity (Chirmule et al., 1999) and they 
induce no clearly defined cytotoxic response (Ponnazhagan et al., 1997). Most 
importantly, AAVs are considered to be non-pathogenic for humans (Monahan and 
Samulski, 2000). So far, 14 different serotypes of AAVs have been described. 
Serotypes differ from each other by the protein composition of their capsid. Different 
serotypes seem to infect certain cell types with a higher efficiency than others. This 
preferential targeting is probably mediated by receptor-mediated endocytosis of the 
AAVs.  
A wild-type AAV has a linear single-stranded DNA (ssDNA) genome of 
approximately 4.7 kilobases (kb), containing only two genes: a “rep” gene and a “cap” 
gene (Figure 1.8 A). The “rep” gene encodes replication proteins; and the “cap” gene 
encodes capsid structural proteins. At each end of the ssDNA, there is a 145 
nucleotide-long double-stranded complementary DNA (cDNA) as inverted terminal 
repeats (ITR), which is important for the replication of the viral plasmid and works as 
the signal sequence for packing virus DNA into the capsid (Lusby et al., 1980; Berns 
et al., 1988; Zhou and Muzyczka, 1998).  
The virus does not encode a polymerase and therefore relies on host cell polymerases 
for genome replication. The 3’-end of the viral genome at the end of one ITR serves 
as a primer to start synthesis of the second DNA strand. The double-stranded DNA 
(dsDNA) is necessary for transcription and thus expression of viral proteins (Brister 
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and Muzyczka, 2000). 
Recombinant AAV (rAAV) is produced by removing the viral genes and replacing 
them with the gene of interest (transgene) (Figure 1.8 B). The viral vectors used in 
this thesis are self-complementary AAVs (scAAVs) (Figure 1.8 C). Each scAAV 
genome contains a mutated ITR (mITR) in the middle connecting two ssDNAs that 
are complementary to each other, and two wild-type ITRs at the ends. Thus, the DNA 
is already double stranded so that it can be directly used for transcription and final 
translation without a duplication step in between making expression faster. The 
important trade-off for this efficiency is the loss of half the coding capacity of the 
vector (McCarty et al., 2001).  
 
Figure 1.8: Schematic drawing of AAVs genome. 
A: Wild type AAV genome with ssDNA containing a “rep” gene and a “cap” gene with ITRs at 
each end.  
B: Conventional rAAV genome with ssDNA containing the transgene with ITRs at each end. 
C: scAAV genome has two complementary transgenes connected by mITR in the middle and 
wild-type ITRs at each end.  
 
1.7 Motivation 
In my master thesis, I focused on the second messenger cGMP in the mouse retina 
and its regulation by nitric oxide in the inner retina. Using a specific antibody against 
cGMP, I visualized cGMP-immunoreactivity (cGMP-IR) in the mouse retina and 
found strongly increased cGMP-IR among many bipolar cells and amacrine cells 
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upon the stimulation with exogenous NO. Genetically encoded cGMP sensor proteins 
are suitable to study the spatiotemporal dynamics of cGMP signaling in living cells. 
This should lead to a better understanding of the NO-cGMP pathway and its role in 
adaptation or modulation of retinal signaling.  
The aim of my thesis is to express the genetically encoded cGMP sensor Cygnet-2.1 
in retinal cells. To this end, appropriate techniques have to be established. First, 
imaging techniques have to be optimized and proof of principle experiments have to 
be performed using Cygnet-2.1 to detect changes in intracellular cGMP in an 
appropriate model system. Second, different serotypes of AAVs have to be tested for 
transduction efficiency on retinal cells. As this can be achieved much more easily in 
vitro than in vivo, as an intermediate step, retinal cell cultures have to be established 
and characterized. Finally, a safe method has to be established for the intraocular 
injection of AAVs in order to transduce neurons in the intact retina in vivo.  
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2.1 Materials  
Chemicals and reagents with purity grade pro analysi (p.a.) were purchased from 
AppliChem (Darmstadt, Germany), Biozym (Hessisch Oldendorf, Germany), Enzo 
(Lörrach, Germany), GE Healthcare (Freiburg, Germany), Merck (Darmstadt, 
Germany), MWG-Biotech (Ebersberg, Germany), Qiagen (Hilden, Germany), Sigma 
(Deisenhofen, Germany) and Sigma-Aldrich (Munich, Germany). Materials for cell 
line culture and primary cell and tissue culture were ordered from GIBCO (Invitrogen, 
Germany). All solutions were prepared with bi-distilled water. Solutions were 
sterilized by filtration or autoclaving for 20 minutes at 121°C, when necessary. 
 
2.2 Cygnet-2.1 calibration in a cell model 
2.2.1 Cell line 
HEK-293 cells are a cell line generated by transformation of human embryonic 
kidney cell cultures with sheared adenovirus 5 DNA (Graham et al., 1977). The FlpTS 
GC-A cell line was modified from HEK-293 cells by stably expressing the cyclic 
nucleotide-gated channel subunit A2 (CNGA2) and the particulate guanylate cyclase 
A (pGC-A). This cell line was kindly provided by Prof. Arnd Baumann’s lab (ICS-4). 
In this project, all FlpTS GC-A cells were seeded on PDL-coated coverslips (Ф 13 
mm) and kept in culture medium DH10 at 37°C, 5% CO2 and 95% humidity.  
 
DH10 
Dulbecco’s Modified Eagle Medium (DMEM; high Glucose, Invitrogen) 
10 %  fetal calf serum (FCS; Gibco/BRL) 
1 %  Glutamax (Gibco/BRL) 
1 %  penicillin-streptomycin (Gibco/BRL) 
1 %  non-essential amino acids (Gibco/BRL) 
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2.2.2 Transient transfection of FlpTS GC-A cells 
Cells for imaging were transiently transfected with the following plasmids either 
alone or in combination: Cygnet-2.1 (Plasmid 19737, AddGene) and cGMP-specific 
phosphodiesterase type 5A (PDE5a; Clone ID: 8991949, Thermo Scientific). Both 
DNAs were introduced into cells via Lipofectamine® 2000 Reagent (Invitrogen).  
For Lipofectamine-transfection, FlpTS GC-A cells were cultured on coverslips (2×104 
cells/coverslip) in multi-well plates. The culture medium DH10 was replaced by 
OPTI-MEM (Invitrogen) (500 μl/well) at least 30 minutes before transfection. The 
transfection assay is described in Table 2.1.  
Table 2.1: Transfection assay for a 13 mm coverslip.  
Single-transfection  Double-transfection  
DNA in H2O 500 ng DNA (Cygnet-2.1) in H2O 500 ng 
Lipofectamine® 2000 1 μl DNA (PDE5a) in H2O 500 ng 
OPTI-MEM 100 μl Lipofectamine® 2000 1.5 μl 
  OPTI-MEM 100 μl 
    
The assay was mixed gently and incubated for 30 minutes at room temperature. Then 
the DNA-Lipofectamine® 2000 complexes were directly pipetted onto the cells 
followed by incubation at 37°C, 5% CO2 and 95% humidity for 3 hours. Thereafter 
the medium was entirely exchanged by fresh DH10 (500 μl/well). 
After 24 hours, the cells could be used for experiments. 
2.2.3 Setup of the measuring chamber 
All imaging was performed in a Plexiglas chamber with a volume of about 400 μl 
(constructed by the workshop of ICS-4) mounted on the microscope stage (Figure 2.1). 
This chamber was sealed with a glass coverslip at the bottom and a transparent lid on 
top. A multichannel perfusion system was connected to the chamber through plastic 
tubes (Neolab, Heidelberg). The perfusion system was driven by gravity and excess 
solution in the chamber was aspirated by a roller pump (Meredos GmbH, Germany). 
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The flow rate was adjusted between 3 and 4 ml/min. 
 
Figure 2.1: Measuring chamber with feed and drain of the perfusion system. 
The feed is installed on the right side, from which solution flowed into the chamber. From the left 
side, the drain constantly removed the excess of bath solution. The coverslip with the cells was 
placed in the center of the chamber. 
 
2.2.4 Calcium-imaging 
2.2.4.1 Setup for Calcium-imaging 
The setup (Figure 2.2) was mainly composed of a Laser source used for wide field 
illumination, an acousto-optical tunable filter (AOTF), an inverted microscope, and an 
electron multiplying charge-coupled-device camera (EMCCD-camera).  
For calcium imaging, Fluo-4-AM (Invitrogen), a fluorescent synthetic Ca2+ indicator 
was used in this project. The excitation and emission maxima of the Ca2+–bound form 
are 494 nm and 506 nm, respectively. All optical elements fitted to that fluorescence 
spectrum. 
A laser beam with a wavelength of 447 nm was generated by a diode laser (MDL III 
447, 500 mW, CNI Laser). It passed through an AOTF (AA.AOTF.nC-T 1001, AA 
Opto-Electronic), which diffracted the laser beam and controlled the exposure time in 
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the millisecond range. From the AOTF, the laser beam was guided by a flexible glass 
fiber to an inverted microscope. 
 
Figure 2.2: Setup for calcium imaging. 
 
Inside the inverted microscope (Model IX70, Olympus), the laser beam was reflected 
by a 505 nm dichroic mirror (505DRLPXR XF2031, Omega Optics) to a 40x 
objective (LCAch Ph2, NA 0.55, Olympus) or a 60x objective (UPlanApo/IR, NA 1.2, 
Olympus), either of which focused the beam onto the sample. The emitted 
fluorescence light from the sample was transmitted through the objective and the 
dichroic mirror and finally projected onto the chip of the EMCCD-camera (iXON 
DU-897D-CSO, Andor Technology). The entire setup was controlled by a personal 
computer running the operation system MCtrl v0.7 programmed by Dr. Johnny 
Hendriks (ICS-4). 
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2.2.4.2 Measurements and data evaluation 
A coverslip with adherent cells was carefully transferred into a 15 mm well containing 
500 μl loading solution (3 μM Fluo-4-AM in ES). In this membrane permeable form, 
the calcium indicator can enter the cell. Once inside the cell, the acetoxymethyl group 
is cleaved by non-specific esterases, thereby generating free Fluo-4 in the cytosol. 
After 30 ~ 45 minutes of loading in the dark, the coverslip with cells was carefully 
placed into the center of the measuring chamber. During the measurement, 
extracellular solution (ES) or ES containing desired agents was continuously applied 
using a perfusion system. Fluo-4 was excited by the 447 nm laser light. Recording of 
pictures was acquired at 1 or 2 Hz and images were stored as stacks of TIF files. 
The original data were processed using ImageJ (Abramoff et al., 2004; Schneider et 
al., 2012). The fluorescence intensity within a region of interest (ROI) was 
determined after subtracting the background intensity. Then the data were further 
progressed according to the formula: 
(Ft − F0) / F0 
F0 is the base line intensity in the ROI; Ft is the intensity in the ROI at the time t in the 
recording. 
All diagrams were produced using Origin 8.0 (OriginLab). 
 
Extracellular solution (ES) 
120 mM   NaCl  
5 mM   KCl  
2 mM   CaCl2  
2 mM   MgCl2  
10 mM   HEPES  
10 mM  Glucose  
* Adjusted to pH=7.4 (with NaOH) 
* Adjusted to an osmolarity of 300 mOsm (with Glucose, 1mM ≈1 mOsm) 
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2.2.5 FRET-based cGMP-imaging 
2.2.5.1 Setup for FRET measurement 
FRET-based imaging was performed on the same setup (Figure 2.3) as calcium 
imaging, except that a beam splitter was employed. 
 
Figure 2.3: Setup for FRET measurement. 
 
During FRET imaging, two fluorescent proteins CFP and YFP were used. For CFP, 
maximal absorption is at 434 nm and maximal emission is at 477 nm. For YFP, 
maximal absorption is at 513 nm and maximal emission is at 527 nm. All the optical 
elements were adjusted to match the two fluorescence spectra. 
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The laser beam of 447 nm wavelength was used to excite CFP. Inside the inverted 
microscope, the laser beam was reflected by a 455 nm dichroic mirror (455DRLP 
XF2034, Omega Optics). The emitted fluorescence light from the sample was 
transmitted through the objective and the dichroic mirror into a beam splitter 
(Optosplit II, Cairn Research). Within the beam splitter a dichroic mirror (505 nm 
DRLP XF2010, Omega Optics) was used to separate CFP emission from YFP 
emission by reflecting light below 505 nm (CFP emission) and transmitting light 
above 505 nm (YFP emission). The CFP component was passed through a 465 to 500 
nm band-pass filter (AF30 Emitter XF3075, Omega Optics) and the YFP component 
through a 520 to 555 nm band-pass filter (AF26 Emitter XF3097, Omega Optics). At 
the output of the beam splitter the two fluorescent images were projected side by side 
onto the chip of the EMCCD-camera.  
2.2.5.2 Measurements and data evaluation 
A coverslip with adherent cells expressing Cygnet-2.1 was carefully transferred into 
the center of the measuring chamber. During measurement, ES or ES containing 
desired agents was continuously applied via the perfusion system. Images were 
captured at 1 or 2 Hz and recorded as stacks of TIF files.  
The original data were initially processed with a series of programs designed by Dr. 
Luru Dai (ICS-4) in the environment of Matlab (The MathWorks). Within the 
programs, the fluorescence signals of a defined ROI in both CFP and YFP channels 
were determined after subtracting the background intensity and a ratio was calculated 
as CFP signal/YFP signal. Afterwards, the ratio (CFP/YFP) was further processed by 
the following formula in Excel (Microsoft): 
(Rt − R0) / R0 
R0 is the base line ratio; Rt is the ratio measured at time t in the recording. 
All diagrams were produced via Origin 8.0.   
23 
 
Materials and Methods 
2.3 Retinal culture  
2.3.1 Animals 
Wild type mice (C57BL/6; Charles River, Germany) were bred in a local colony. 
Animals aged between postnatal day 2 and 8 (P2 to P8) were used. All procedures 
were approved by the local animal care committee of the Forschungszentrum Jülich 
(Tierschutzbeauftragte) and were in accordance with the law of animal 
experimentation issued by the German Government (Tierschutzgesetz). Ocular 
injections were performed according to LANUV NRW, Aktenzeichen 
84-02.04.2011.A331. 
2.3.2 Organotypic retinal whole-mount culture 
2.3.2.1 Primary culture 
C57BL/6 mice at P8 were deeply anaesthetized with isoflurane and quickly 
decapitated. The eyes were quickly enucleated and collected in Hank´s Balanced Salt 
Solution (Hank's; Sigma-Aldrich). The front part of the eye (cornea, lens, and vitreous) 
was discarded and the retina carefully isolated from the pigment epithelium. The 
intact retinae were then transferred into either 35 mm petri dishes or 6-well plates 
containing Millicell-HA inserts (pore size 0.45 μm, Ф 30 mm; Millipore) (Figure2.4).  
  
Figure 2.4: Millicell-HA inserts. 
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Retinae were mounted onto the membrane of the inserts in either one of two ways 
(Figure 2.5): A) flat mounted with the photoreceptors facing the filter and the 
ganglion cell layer facing up; B) following their natural curvature. In this preparation 
the photoreceptors faced up while the ganglion cells were sandwiched in the middle. 
 
Figure 2.5: Schematic diagram of organotypic retinal whole-mount culture. 
 
Afterwards, 1500 μl of modified DMEM medium (mDMEM) was added to the well. 
The cultures were kept at 37°C, 5% CO2 and 95% humidity and 50% of the medium 
was changed every two days. Retinae were cultivated for 2, 4, 8, 12, and 16 days. 
 
Modified DMEM (mDMEM) 
42.25 ml  DMEM, High Glucose, GlutaMAX (Gibco) 
0.5 ml  Antibiotic-Antimycotic, 100X (Gibco) 
0.5 ml  Sodium-Pyruvate (Sigma-Aldrich) 
0.5 ml  N2-Supplement, 100X (Invitrogen) 
5 ml  FCS (Gibco/BRL) 
1.25 ml  HEPES solution, 1 M, pH=7.4 (Sigma-Aldrich) 
 
2.3.2.2 Immunocytochemistry  
Retinal whole-mount cultures were fixed in 4% paraformaldehyde in 0.1 M phosphate 
buffer (PB) for 30 minutes at room temperature. Upon fixation, the cultures were 
washed in PB for 10 to 15 min. To section the whole-mount cultures, the retinae were 
cryoprotected by infiltration with 10% sucrose/PB for 2 hours and 30% sucrose/PB 
over-night, respectively. After being frozen in TissueTek (OCT; Fisher Scientific), 
retinal cultures were vertically sectioned (i.e. perpendicular to the layering) in a 
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thickness of 20 μm under optimum cutting temperature. Sections were collected on 
Superfrost plus glass slides (Thermo Scientific). Sections were blocked by incubation 
in CTA, and were then incubated overnight in the same solution containing the 
antibodies of interest. After washing in PB, sections were incubated with the 
appropriate fluorescent-labeled secondary antibody for 1 hour.  
Control experiments included omission of the primary antibody and observation of 
only secondary antibodies labeled slides through the appropriate filter set. Sections 
were coverslipped using Aqua Polymount (Polysciences, Germany). The final 
analysis was performed using laser scanning confocal microscopy (Leica, see 2.3.5) 
using optimal settings.  
 
Phosphate Buffer (0.1 M, PB)  Paraformaldehyde  
81 mM  Na2HPO4  4 % paraformaldehyde  
19 mM  NaH2PO4  * in 0.1 M PB  
* in distilled water    
* pH=7.4    
 
CTA  
5 %  Chemiblocker (Chemicon) 
0.5 %  Triton-X 100 (Sigma) 
0.05 %  NaN3 
* in 0.1 M PB 
 
2.3.3 Dissociated retinal cell culture 
2.3.3.1 Primary culture 
Dissociated retinal cells were seeded onto 13 mm coverslips. Before seeding, 
coverslips were coated with 150 µl of a 0.1 mg/ml Poly-D-Lysine (PDL) solution at 
room temperature overnight. Following 2 times washing with sterile distilled water, 
coverslips were incubated in 100 µl of a 10 µg/ml Laminin solution at room 
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temperature for at least 3 hours. Laminin solution was aspirated immediately before 
seeding of cells.  
C57BL/6 mice of postnatal day 2 to 4 (P2 to P4) were decapitated after deep 
anesthetization with isoflurane. The eyes were quickly enucleated and collected in 
Hank's. The front part of the eye (cornea, lens, and vitreous) was discarded and the 
retina was isolated from the pigment epithelium. The retinae were then transferred 
into a tube containing Calcium-Magnesium-free Hank’s Balanced Salt Solution 
(CMF-Hank’s; Sigma-Aldrich) and maintained for about 10 minutes. Following brief 
centrifugation and aspirating the supernatant, pre-warmed papain solution (20 
units/ml in CMF-Hank’s; Worthington, US) was applied and retinae were incubated 
for 20 minutes at 37°C. Afterwards, papain solution was removed and the retinae were 
washed twice with mDMEM to inactivate papain. Cells were gently dissociated by 
pipetting the retinae up and down through a 100 µl plastic tip (Nerbe Plus, Germany). 
When the tissue was fully dissociated, the cell suspension was adjusted by extra 
mDMEM to reach the concentration of 2000 cells/µl. For seeding, 150 μl of adjusted 
cell suspension containing 300000 cells was carefully added onto the coated surface 
of every coverslip in 15 mm wells and kept at 37°C, 5% CO2 and 95% humidity for 
about 1 hour to allow cells to adhere. Finally, 350 µl of fresh mDMEM was added in 
order to increase the volume of the medium to 500 µl per well. Cultures were kept at 
37°C, 5% CO2 and 95% humidity, and 50% of the medium was changed every second 
day up to 4 weeks.  
 
Poly-D-Lysine solution (0.1mg/ml, PDL) Laminin solution (10µg/ml) 
5 mg PDL (Sigma-Aldrich) 100 µl Laminin (1 mg/ml, Sigma-Aldrich) 
50 ml distilled water 10 ml distilled water 
 
Papain Solution (20 units/ml) 
100 units Papain (Worthington) 
5 ml CMF-Hank’s 
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2.3.3.2 Immunocytochemistry  
Immunocytochemistry for dissociated retinal cell cultures was performed on the glass 
coverslips and followed the same steps as described before (Chapter 2.3.2.2), except 
for the following modifications: 1) the fixation time was reduced to 10 minutes; 2) the 
incubation time was 1 hour for primary antibodies and 0.5 hour for secondary 
antibodies.  
2.3.4 Organotypic retinal slice cultures 
2.3.4.1 Primary culture 
C57BL/6 mice at P8 were decapitated after deep anesthetization with isoflurane. The 
eyes were quickly enucleated and collected in Hank's. The front part of the eye 
(cornea, lens, and vitreous) was discarded and the retina was carefully isolated from 
the pigment epithelium. A tissue chopper (The Mickle Laboratory Engineering Co. 
Ltd., UK) was used to cut the retinae into vertical slices (perpendicular to the layering) 
with different thickness (150 μm or 250 μm). These slices were very carefully 
transferred into 35 mm petri dishes containing Millicell-HA inserts. In this preparation, 
slices attached with the cut surface to the filter and photoreceptors and ganglion cells 
faced either side of the slice. Afterwards, 1000 μl of mDMEM was added to the petri 
dishes. The cultures were kept at 37°C, 5% CO2 and 95% humidity, and 50% of the 
medium was changed every two days. The retinae were cultivated for 2, 4, 6, and 8 
days.  
2.3.4.2 Immunocytochemistry  
Retinal slice cultures were immunocytochemically stained intact on the filter. Staining 
procedure followed the same steps as described before (Chapter 2.3.2.2).  
2.3.5 Native retina preparation and immunohistochemistry 
C57BL/6 mice aged P8 to P24 were deeply anaesthetized with isoflurane and quickly 
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decapitated. The eyes were quickly enucleated and collected in Hank´s Balanced Salt 
Solution. The front part of the eye (cornea, lens, and vitreous) was discarded and the 
posterior part with the retina was fixed in 4% paraformaldehyde (in PB) for 30 
minutes at room temperature. Upon fixation, the eye cups containing the retina were 
washed in PB for 10 to 15 minutes and, then cryoprotected by infiltration with 10% 
sucrose (in PB) for 2 hours and 30% sucrose (in PB) over-night, respectively. 
Thereafter, the retinae were carefully isolated from the eye cups and flat mounted on 
parafilm. After being frozen in TissueTek, retinae were vertically sectioned in a 
thickness of 20 μm under optimum cutting temperature. Sections were collected on 
Superfrost plus glass slides. Immunohistochemistry for native retinal sections was 
performed following the same steps as described in Chapter 2.3.2.2.  
2.3.6 Confocal laser scanning microscopy 
Immunofluorescence and differential interference contrast (DIC) images of retinal 
cultures and retinal sections were obtained by using a Leica TCS SP5II laser scanning 
confocal microscope (Leica Microsystems, Germany). The intensity of laser and filter 
settings were carefully controlled by the Leica LAS AF software. Wavelengths of 458 
nm (for CFP) and 488 nm (for Cy2, GFP) generated by an argon laser and 
wavelengths of 543 nm (for Cy3), 594 nm (for Alexa594) and 633 nm (for Cy5, 
Alexa647, DyLight649, TO-PRO®3) generated by different HeNe lasers were used. 
All fluorescence micrographs were artificially colored. In addition, the sequential 
scanning mode was applied to rule out cross-talk between the fluorescence detection 
channels for samples with multiple stainings. Band pass filter of 465 - 490 nm for CFP, 
500 - 540 nm for Cy2 and GFP, 555 - 605 nm for Cy3, 610 - 635 nm for Alexa594, 
and 650 - 750 nm for Cy5, Alexa647, DyLight649, TO-PRO®3 were used. Images 
were further processed in ImageJ and Adobe Photoshop (Adobe Systems, San Jose, 
CA) to optimize contrast and brightness. The layout was processed in Adobe 
Illustrator (Adobe Systems, San Jose, CA).  
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2.4 Adeno-associated viruses mediated transduction 
All adeno-associated viruses (AAVs) used in this project were kindly provided by 
Prof. Arnd Baumann’s lab (Table 2.1). AAV serotypes encoding green fluorescent 
protein (GFP) were used for initial testing of transduction efficiency. AAV2 encoding 
the cGMP sensor Cygnet-2.1 was used for Cygnet-2.1 expression in retinal cells. All 
viruses were stored in 40% iodixanol at - 20°C. 
Table 2.2: AAVs used for transduction.  
AAVs Concentration (viral particles/μl ) 
AAV1-GFP 1.036×109 
AAV2-GFP 1.780×109 
AAV4-GFP 1.950×109 
AAV6-GFP 3.666×109 
AAV8-GFP 8.885×109 
AAV9-GFP 1.072×1010 
AAV2-Cygnet-2.1 9.300×107 
  
2.4.1 AAV mediated transduction of organotypic retinal whole-mount cultures 
AAV mediated transduction in retinal whole-mount cultures was performed after two 
days in culture. Each AAV serotype was pre-diluted with mDMEM to obtain a 
concentration of 1×1010 vp/20 μl. For transduction, inserts with cultivated retinae were 
moved into dry and clean petri dishes. Then, 20 μl of the pre-diluted virus solution 
were directly pipetted onto the surface of each cultivated retina. Cultures were 
incubated with the virus solution at 37°C, 5% CO2 and 95% humidity for 15 minutes. 
Thereafter, cultures were transferred back into the original culture plate with medium 
and were cultured for another 6 days. Then, the cultures were fixed for 
immunochemical studies. 
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2.4.2 AAV mediated transduction of dissociated retinal cell cultures 
AAV mediated transduction on dissociated retinal cultures was performed two days 
after seeding. AAV serotypes were pre-diluted individually within mDMEM to obtain 
a concentration of 1×109 vp/300 μl. All cultures to be transduced were transferred into 
new dry and clean 4- or 24-well plates, depending on the number of cultures. Then, 
300 μl of pre-diluted virus solution were added into each well. After two days, 200 μl 
of fresh mDMEM were added to each well. After another 6 to 8 days of cultivation, 
the cultures were used for imaging experiments or fixed for immunochemical studies.   
2.4.3 AAV mediated transduction of FlpTS GC-A cells 
AAV mediated transduction on dissociated retinal cultures was performed two days 
after seeding. AAV2-Cygnet-2.1 was pre-diluted with DH10 to obtain a concentration 
of 1×109 vp/300 μl. All cultures to be transduced were transferred into new dry and 
clean 4- or 24-well plates, depending on the number of cultures. Then, 300 μl of 
pre-diluted virus solution were added into each well and coverslips were cultured 
overnight. On the next day, extra 200 μl of fresh DH10 were added to each well. After 
another 3 to 4 days of cultivation, cultures were used for imaging experiments.  
 
2.5 Ocular injection in vivo  
2.5.1 Micro-injection system 
Micro volumes were precisely delivered via a micro-injection system (Figure 2.6). 
This system was composed of a 10 µl-micro syringe (World Precision Instruments, 
Germany) connected with a 33-gauge beveled needle (World Precision Instruments, 
Germany) through a polyethylene tube (ID 0.38 mm; AgnTho’s AB, Sweden). The 
syringe was mounted on and driven by an UltraMicroPump III (World Precision 
Instruments, Germany) which was precisely controlled by a SYS-MICRO4 controller 
(World Precision Instruments, Germany). The syringe, tube and needle were pre-filled 
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with mineral oil (Sigma-Aldrich). Before injection, about 5 µl of oil was displaced 
and the same volume of solution was sucked into the tube through the needle.  
 
Figure 2.6: Micro-injection system for ocular injection. 
 
2.5.2 Operation for ocular injection 
C57BL/6 mice at postnatal day 5 (P5) were chosen for ocular injection. Mice were 
anesthetized by subcutaneous injection with a defined volume (10 μl/g body weight) 
of an anesthetic cocktail (Table 2.3).  
Table 2.3: Prescription of anesthetic and antidote cocktail.  
Anesthetic  
Medetomidine  (1 mg/ml; Elanco, Germany) 50 μl 
Midazolam  (1 mg/ml; Actavis, Germany) 100 μl 
Fentanyl  (0.1 mg/ml; Janssen-CILAG, Germany) 100 μl 
0.9% sterile NaCl  (Berlin-Chemie, Germany) 750 μl 
Antidote  
Atipamezole  (5 mg/ml; Elanco, Germany) 50 μl 
Flumazenil  (0.1 mg/ml; Fresenius Kabi, Germany) 500 μl 
Naloxone  (0.4 mg/ml; ratiopharm, Germany) 300 μl 
0.9% sterile NaCl 150 μl 
* All pharmaceuticals were provided and controlled by the animal facility. 
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The entire operation was carried out under a dissecting microscope (Leica 
Microsystems, Germany). The pup was placed on a heating plate adjusted to 37°C. 
Once the pup was anesthetized, the skin that covered the eye was cut open with a 
scalpel blade along the fusion line of the two eyelids. The cutting was performed very 
gently without damaging the eye. A small incision was made in the sclera near the 
junction with the cornea using a 20-gauge needle and the 33-gauge beveled needle 
was inserted through the incision into the eye ball (Figure 2.7). 
 
Figure 2.7: Rendering of a subretinal injection.  
This image shows an artist's rendering of a surgery in which a solution is injected into the 
subretinal space. (AP / Moorfields Eye Hospital & University College London) 
(http://media1.s-nbcnews.com/j/msnbc/Components/Photo_StoryLevel/080427/080427-vision-bco
l-3p.grid-6x2.jpg)  
 
0.5 µl of AAVs’ stock solution (Table 2.2) were injected into the eye through the 
needle. At P5 the lens is still milky. Because the vision through the pupil was not clear, 
the exact injection position could not be monitored. For safety, before the injection 
was made the needle was slightly advanced backwards after reaching the bottom of 
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the eye. In that way, the viruses were injected as close to the retina as possible. After 
pulling out the needle a little amount of Refobacin Augensalbe (Merck) was smeared 
at the wound of the cover skin in order to reduce the risk of infection. A defined 
volume (10 μl/g body weight) of an antidote cocktail (Table 2.3) was injected 
subcutaneously. When the pups had recovered from anesthesia, they were returned to 
their mother.  
2.5.3 Immunohistochemistry 
Injected mice were kept for 4 to 8 weeks to allow for expression. Finally, mice were 
deeply anaesthetized with isoflurane and quickly decapitated. The eyes were quickly 
enucleated and collected in Hank´s. The front part (the cornea, lens, and vitreous) of 
the eye was discarded and the retina carefully isolated from the pigment epithelium. 
The following steps for immunohistochemistry were performed as described in 
chapter 2.3.2.2.  
 
2.6 NO induced cGMP-immunoreactivity (cGMP-IR) in dissociated retinal 
cultures 
Dissociated retinal cultures were used 3 to 4 days after seeding. Cultures were 
incubated in Ames’ medium (Sigma-Aldrich, bubbled with 95% O2 and 5% CO2, pH 
7.4) at room temperature for 10 minutes, which contained none or either one of the 
two NO donors: 100 μM S-nitroso-N-acetylpenicillamine (SNAP; Enzo) and 1 mM 
sodium nitroprusside dihydrate (SNP; Sigma-Aldrich).  
After incubation, the cultures were fixed in 4% paraformaldehyde for 10 minutes at 
room temperature. Upon fixation, the cultures were immediately processed for 
immunocytochemistry following the protocol described in Chapter 2.3.3.2.   
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2.7 cGMP-imaging of dissociated retinal cultures upon transient transfection 
Transient transfection of dissociated retinal cultures with Cygnet-2.1 was performed 
two days after seeding. The DNA was introduced into retinal cells using the 
Lipofectamine® 2000 Reagent. The transfection assay is described in Table 2.4. 
Table 2.4: Transfection assay for retinal dissociated culture on a 13 mm coverslip.  
Single-transfection  
DNA in H2O 500 ng 
Lipofectamine® 2000 1 μl 
OPTI-MEM 100 μl 
  
The assay was mixed gently and incubated for 30 minutes at room temperature. The 
culture medium was removed from the well and the DNA-Lipofectamine® 2000 
complexes were directly pipetted onto the cells followed by incubation at 37°C, 5% 
CO2 and 95% humidity for 3 hours. At the end of transfection, the solution was 
aspirated and the cells were incubated in fresh mDMEM (500 μl/well). 
After 24 hours, the cultures could be used for imaging experiments. 
The cGMP-imaging in dissociated retinal cultures followed the protocol described in 
2.2.4 except that the incubation solution was replaced by Ames’ medium. Solutions 
containing NO donors were prepared immediately before the imaging experiments.  
 
2.8 Antibodies  
Primary antibodies used in this study are described in Table 2.5.  
Secondary antibodies used in this study are described in Table 2.6. 
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Table 2.5: List of primary antibodies. 
Antibody Antigen Dilution Species Source 
Blue opsin blue-sensitive opsin 1:200 
Goat 
polyclonal 
Santa Cruz (sc-14365) 
CaBP Calbindin 28K 1:1000 
Mouse 
monoclonal 
Sigma (c-8666) 
CaBP5 
calcium binding protein 
5 
1:1600 
Rabbit 
polyclonal 
F. Haeseleer, Department of 
Ophthalmology, Seattle, WA 
Calretinin calretinin 1:10000 
Rabbit 
polyclonal 
Swant (7699/4) 
cGMP 
cGMP-formaldehyde- 
thyroglobulin complex 
1:3000 
Sheep 
polyclonal 
Dr. Jan De Vente, 
The Rijksuniversiteit 
Limburg, The Netherlands 
GAD65 
glutamic acid 
decarboxylase isoform 
65 
1:4000 
Mouse 
monoclonal 
Abcam (ab26113) 
GAD67 
glutamic acid 
decarboxylase isoform 
67 
1:4000 
Rabbit 
polyclonal 
Chemicon (AB108) 
GFAP 
glial fibrillary acidic 
protein 
1:400 
Mouse 
monoclonal 
Sigma-Aldrich (G3893) 
GFP 
green fluorescent 
protein 
1:1000 
Mouse 
monoclonal 
Chemicon (MAB3580) 
GFP 
green fluorescent 
protein 
1:8000 
Rabbit 
polyclonal 
Abcam (ab290) 
GFP 
green fluorescent 
protein 
1:1000 
Chicken 
polyclonal 
Chemicon (AB16901) 
GlyT1 glycine transporter 1 1:2000 
Goat 
polyclonal 
Chemicon (AB1770) 
GS glutamine synthetase 1:2000 
Mouse 
monoclonal 
BD Biosciences (610517) 
NOS 
neuronal nitric oxide 
synthase 
1:4000 
Rabbit 
polyclonal 
Sigma (N7280) 
PKARIIβ 
protein kinase A, 
regulatory subunit IIβ 
1:4000 
Mouse 
monoclonal 
BD Biosciences (P54720) 
PKCα 
protein kinase C, α 
isoform 
1:2000 
Mouse 
monoclonal 
Transduction laboratories 
(P20420) 
Recoverin recoverin 1:2000 
Rabbit 
polyclonal 
Chemicon (AB5585) 
Rhodopsin rhodopsin 1:500 
Mouse 
monoclonal 
Dr. Robert S.Molday, 
The University of British 
Columbia 
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Antibody Antigen Dilution Species Source 
sGC 
soluble guanylate 
cyclase, subunit β1 
1:500 
Rabbit 
polyclonal 
Cayman Chemicals, Ann 
Arbor, MI (160897) 
Syt2 
synaptic vesicle 
associated protein 
synaptotagmin-2 
1:1000 
Mouse 
monoclonal 
Zebrafish International 
Resource Center 
(ZDB-ATB-081002-25) 
TH tyrosine hydroxylase 1:500 Chicken Neuromics (CH23006) 
TH tyrosine hydroxylase 1:500 
Mouse 
monoclonal 
Sigma (T2928) 
     
Table 2.6: List of secondary antibodies and nuclear stain. 
Antibody Dilution Species Source 
Anti-chicken CyTM2 1:200 donkey Dianova 
Anti-chicken DyLightTM649 1:800 goat Dianova 
Anti-goat CyTM2 1:400 donkey Dianova 
Anti-goat CyTM3 1:1000 donkey Dianova 
Anti-goat Alexa Fluor® 594 1:1000 donkey Dianova 
Anti-goat Alexa Fluor® 647 1:200 donkey Invitrogen 
Anti-mouse CyTM2 1:100 donkey Dianova 
Anti-mouse CyTM3 1:100 donkey Dianova 
Anti-mouse Alexa Fluor® 594 1:500 donkey Dianova 
Anti-mouse DyLightTM649 1:500 donkey Dianova 
Anti-rabbit CyTM2 1:400 donkey Dianova 
Anti-rabbit CyTM3 1:500 donkey Dianova 
Anti-rabbit Alexa Fluor® 594 1:1000 donkey Dianova 
Anti-rabbit DyLightTM649 1:500 donkey Dianova 
TO-PRO®3 1:1000 - Invitrogen 
 
 
37 
 
3. RESULTS 
The aim of this study was to establish methods that would allow to spatially and 
temporally monitor the dynamics of the second messenger cGMP in retinal neurons 
using the genetically encoded cGMP sensor Cygnet-2.1. The functionality of 
Cygnet-2.1 was first demonstrated in a cell model – the FlpTS GC-A cell line 
originated from the HEK-293 cell line. The most challenging aspect of the study is the 
expression of Cygnet-2.1 in the intact mouse retina in vivo. Recombinant 
adeno-associated viruses (AAVs) were chosen as gene ferries to deliver DNA into 
retinal cells. In a first step, different types of retina cultures were established and were 
used to characterize the performance of seven different AAV serotypes coding for GFP. 
Thereafter, six selected serotypes of AAVs were used to infect retinal cells in vivo via 
ocular injection and for each serotype transduction pattern and efficiency were 
characterized. Comparative analysis between the results obtained in vitro and in vivo 
determined AAV serotype II (AAV2) as a suitable vector to express Cygnet-2.1 in 
retinal cells. Finally, the functionality of Cygnet-2.1 expressed upon AAV2 
transduction was further examined by cGMP-imaging in both retina cultures and 
FlpTS GC-A cells. 
3.1 Characterization of Cygnet-2.1 in the model system FlpTS GC-A  
3.1.1 Calcium-imaging in FlpTS GC-A cells 
Cygnet-2.1 was characterized in the model cell line FlpTS GC-A. This cell line is 
derived from HEK-293 cells and expresses the particulate guanylate cyclase A 
(pGC-A) as well as a cyclic nucleotide-gated (CNG) channel composed of CNGA2 
subunits. The atrial natriuretic peptide (ANP) activates the pGC-A which in turn 
synthesizes cGMP. A rise in intracellular cGMP leads to CNG channel activation and, 
hence, calcium influx. The changes in the intracellular calcium concentration can, 
therefore, be used to indirectly monitor the changes in the intracellular cGMP 
concentration.  
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In initial experiments, cells were incubated with the membrane permeable variant of 
the calcium indicator Fluo-4 for 30 to 40 minutes. Cells were transferred to the 
perfusion chamber of the imaging setup, constantly perfused with extracellular 
solution (ES) and the Fluo-4 fluorescence was detected using a camera. During 
recording, cells were superfused with ES containing 10 nM ANP for 1 minute. In 
Figure 3.1.1, the fluorescence signal of regions of interest (ROIs) recorded from three 
cells is plotted over time. The ROIs were defined to cover an individual cell entirely. 
The fluorescence signal is displayed as the change ΔF in fluorescence intensity 
divided by the initial fluorescence intensity F0. A rapid increase in the fluorescence 
was detected approximately 20 seconds after the onset of ANP application. This delay 
was observed in all imaging experiments and is due to the time span needed to 
exchange the medium in the recording chamber. During the period of application, the 
fluorescence intensity decreased to a slightly lower level (about 88% of the peak). 
Upon washout of ANP, the fluorescence did not recover to the baseline level but 
remained at this elevated level until the end of the recording (5 minutes). In all traces, 
0.16 Hz fluctuations can be observed. The fluctuations are perfectly synchronized 
between the cells and probably reflect a slight instability in the performance of the 
laser or the AOTF in the excitation pathway of the imaging setup.  
As Fluo-4 acts as a calcium indicator, the increase in fluorescence intensity can be 
interpreted as a rise in the internal calcium concentration upon stimulation of the cell 
with ANP. 
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Figure 3.1.1: Fluorescence intensity of the calcium sensor Fluo-4 increased in 
FlpTS GC-A cells upon stimulation with ANP.  
The fluorescence signal of three FlpTS GC-A cells loaded with Fluo-4 (indicated in the screenshot) 
is displayed. ANP (10 nM) was applied from 30 to 90 seconds. All cells showed a rapid increase of 
the Fluo-4 fluorescence, indicating a rise in the intracellular calcium concentration upon the 
stimulation with ANP. Interestingly, the fluorescence remained elevated after washing with ES for 
5 minutes.   
Scale bar = 20 µm. in screenshot 
 
According to the signaling pathway of the FlpTS GC-A cells, the calcium influx is 
triggered by the opening of the CNG channels and, therefore, depends on the level of 
the intracellular cGMP concentration. The rise in the internal calcium concentration 
results from the activation of pGC-A by ANP. However, upon washout of ANP a 
decrease of the internal calcium concentration would have been expected as under 
other experimental paradigms calcium is readily cleared from the cytoplasm of 
HEK-293 cells (data not shown). One possible explanation would be that the cGMP 
concentration remains high even after ANP application was terminated, leading to a 
constant activation of CNG channels and, hence, constant influx of calcium. This 
hypothesis was tested by using the cGMP sensor Cygnet-2.1.  
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3.1.2 FRET-based cGMP-imaging in FlpTS GC-A cells 
The cDNA encoding Cygnet-2.1 was transiently transfected into FlpTS GC-A cells by 
means of Lipofectamine® 2000 reagent. After expression for about 24 hours, cells 
were used for imaging. 
Figure 3.1.2 shows one screenshot capturing two cells during an imaging experiment. 
Cygnet-2.1 is a FRET-based sensor. A beam splitter was used to separate the 
fluorescence signals into two parts: CFP fluorescence below 505 nm and YFP 
fluorescence above 505 nm. Both images were projected by the beam splitter side by 
side onto the camera chip. The upper part displays the image originating from CFP 
fluorescence; the lower part shows the identical image displaying YFP fluorescence. A 
healthy FlpTS GC-A cell transfected with Cygnet-2.1 usually shows the fluorescence 
mainly in the cytoplasm, while the nucleus is devoid of fluorescence.  
 
Figure 3.1.2: Screenshot from a FRET imaging experiment on FlpTS GC-A cells 
expressing Cygnet-2.1.  
Two cells were captured. The upper panel (above the dashed line) represents the image in the CFP 
channel, while the lower panel (below the dashed line) reflects the image in the YFP channel. Note 
that fluorescence is only found in the cytoplasm of the cell. 
Scale bar = 20 µm. 
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ROIs were adjusted to each cell and fluorescence intensity in both CFP and YFP 
channels was measured and plotted in artificial units over time. Figure 3.1.3 shows the 
result from cell 1. 
During the whole recording, cells were constantly superfused with ES. The baseline 
intensity was stable during the ES perfusion. After the onset of ES containing 10 nM 
ANP, the CFP intensity increased while the YPF intensity decreased. The changes of 
CFP intensity and YFP intensity were mirror reversed. This is to be expected as 
binding of cGMP to the sensor Cygnet-2.1 reduces the efficiency of FRET between 
CFP and YFP. Similar to the calcium-imaging experiments as shown in Figure 3.1.1, 
the signals did not fully recover to baseline upon washout of ANP.  
 
Figure 3.1.3: Fluorescence intensity of CFP and YFP for cell 1 during one 
recording. 
CFP and YFP fluorescence was plotted in artificial units (A.U.) over time (CFP in cyan and YFP 
in orange). During the application of ANP (10 nM), the CFP fluorescence intensity increased, 
while the YFP fluorescence intensity decreased. The mirror reversed changes of CFP and YFP 
fluorescence are to be expected, if the FRET efficiency between the two fluorescent proteins is 
reduced by binding of cGMP to Cygnet-2.1. Note that the signals did not recover to baseline upon 
washout of ANP. 
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In the following, the signal was depicted as the ratio of CFP/YFP by dividing the CFP 
fluorescence intensity by the YFP fluorescence intensity. The ratiometric depiction 
also reduces artefacts that originate from instabilities of the excitation pathway of the 
imaging setup or from the movements of the cells during perfusion as fluorescence 
intensities of CFP and YFP are affected by such artefacts in the same way. In the 
ratiometric depiction (Figure 3.1.4), the curve of CFP/YFP is much smoother and less 
noisy than the original traces depicted in Figure 3.1.3. 
As Cygnet-2.1 works as a FRET-based cGMP sensor, the reduction of FRET is due to 
the cGMP binding and, hence, the increase in the ratio of CFP/YFP can be interpreted 
as a rise in the intracellular cGMP concentration upon stimulation of the cell.   
 
Figure 3.1.4: Ratio of CFP/YFP for cell 1 during one recording. 
The ratio of CFP/YFP is plotted over time. A sharp increase was observed during the application 
of ANP, which can be interpreted as a reduction in FRET efficiency upon the binding of cGMP to 
the sensors and, therefore, as a rise in the cGMP concentration.  
 
In Figure 3.1.4, the baseline ratio of CFP/YFP for cell 1 was around 0.3 before ANP 
application. Upon the stimulation with ANP, the ratio readily climbed to a plateau at 
around 0.355, representing an 18.3% change of the ratio (or FRET change). 
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Interestingly, upon washout of ANP the value of the ratio only slightly decreased but 
did not recover to the baseline level. This is reminiscent of the calcium imaging 
experiments that had revealed a prolonged increase in the intracellular calcium level 
(Figure 3.1.3).  
In Figure 3.1.5, the FRET change for both cell 1 and cell 2 captured in Figure 3.1.2 
was normalized as the change in CFP/YFP ratio (ΔR) divided by the initial ratio (R0) 
and plotted over time. Both curves show a fast increase to about 0.18 upon the 
stimulation with ANP, which represents a change in FRET efficiency of 18%. 
Compared to cell 1, for cell 2 the cGMP increase upon ANP application was delayed 
for about 10 seconds. This difference might reflect differences between individual 
cells. In both cells the signal decreased very little upon washout of ANP. 
 
Figure 3.1.5: ANP stimulation increases cGMP concentration in FlpTS GC-A cells. 
The FRET change observed in two FlpTS GC-A cells transiently transfected with Cygnet-2.1 was 
plotted over time. ANP (10 nM) was applied from 30 to 90 seconds. Both cells showed a fast 
increase ΔR of the ratio CFP/YFP to ~0.18 indicating a rise in the intracellular cGMP 
concentration upon stimulation with ANP. After a 5-minute washout, the ratios decreased by 0.06 
for both cells but did not reach the baseline level by the end of the recording.  
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The slight decrease in both traces during the washing phase indicates that it takes a 
long time for the intracellular cGMP concentration to return to the baseline level. In 
the following experiments I changed the experimental parameters. First, the ANP 
concentration was reduced to 1 nM to avoid saturation of the response. A KD value 0.1 
to 1 nM has been described for the pGC-A (Jacobs et al., 1987; Pandey, 1997). 
Secondly, the ES washing time was extended to 10 minutes. The results for five cells 
are shown in Figure 3.1.6.   
 
Figure 3.1.6: The fluorescence signals do not recover to baseline even with low 
ANP concentration and prolonged washout.  
The FRET change of five FlpTS GC-A cells transiently transfected with Cygnet-2.1 was plotted 
over time. ANP (1 nM) was applied from 30 to 90 seconds. Upon the stimulation with ANP, the 
FRET change of Cygnet-2.1 indicated a rapid increase in the intracellular cGMP concentration in 
all cells. Despite washing for nearly 10 minutes, in none of the cells the signal recovered to the 
baseline level. 
 
In Figure 3.1.6, five cells were recorded. For all cells, a rapid increase in cGMP 
concentration was observed during the application of 1 nM ANP. FRET changes were 
in the range of 14% to 24.5%, similar in amplitude to the responses observed upon the 
stimulation with 10 nM ANP (12% ~ 25%, n=22). Again, no recovery was observed 
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after washout of ANP.  
Upon a further reduction in the ANP concentration to 0.5 nM, cellular responses 
became inconsistent. Some cells showed large responses, however with a long delay, 
while other cells did not respond at all (data not shown). Therefore, an ANP 
concentration of 1 nM was used in the following experiments.  
In summary, the results indicated that upon stimulation of the pGC-A with ANP, the 
sensor Cygnet-2.1 displayed a fast increase in the ratio CFP/YFP, but the signal did 
not return to baseline levels even during prolonged washout phases. There are several 
explanations for this behavior.   
1) The sensor may not reflect the change in the intracellular cGMP level properly. If 
the dissociation of cGMP from the sensor is slow, the cGMP-induced change in 
the sensor conformation and FRET rate might persist for a long time, even after 
the cGMP level has decreased.  
2) ANP might bind to the pGC-A in a non-reversible or slowly reversible manner. 
Therefore, cGMP synthesis in the FlpTS GC-A cell line might continue during the 
washout phase. 
3) The FlpTS GC-A cells might lack a phosphodiesterase capable of cleaving cGMP. 
As a consequence, the intracellular cGMP concentration would remain high even 
after washout of ANP.  
The first possibility is rather unlikely. In the calcium-imaging experiments (Chapter 
3.1.1), calcium levels were also found to remain elevated for a long time after 
washout of ANP. The second and third possibilities reflect problems unrelated to the 
functionality of Cygnet-2.1. Nevertheless, I tested between both possibilities by 
expressing the cGMP-specific phosphodiesterase type 5a (PDE5a) in FlpTS GC-A 
cells.   
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3.1.3 In the presence of the cGMP-specific PDE5a Cygnet-2.1 displays rapidly 
reversible signals in FlpTS GC-A cells 
The cDNA encoding PDE5a was transiently transfected together with Cygnet-2.1 into 
FlpTS GC-A cells by the use of Lipofectamine® 2000 reagent. After 24 hours of 
expression, the cells were used for imaging experiments.  
 
Figure 3.1.7: ANP-induced cGMP signal rapidly recovers to baseline in the 
presence of PDE5a. 
The FRET change of three FlpTS GC-A cells transiently co-transfected with Cygnet-2.1 and 
PDE5a was plotted over time. ANP (1 nM) was applied during seconds 30 to 90 and 210 to 270. 
All cells showed rapid FRET changes after both onset and offset of ANP, which indicates the 
transient elevation of the intracellular cGMP concentration during the stimulation with ANP.  
 
One of the experiments is shown in Figure 3.1.7. The FRET changes recorded from 
three FlpTS GC-A cells are plotted. Upon the stimulation with 1 nM ANP in all three 
cells a rapid FRET change albeit of different amplitudes was recorded. Around 15 
seconds after the application of ANP had been stopped, the signal of all three cells 
quickly returned to the baseline level. Increase and decrease of the signals occurred in 
the same time range. These data suggest that the prolonged signals shown in Figure 
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3.1.5 and 3.1.6 reflect the prolonged increase in cGMP concentration due to the 
incapability of the endogenous phosphodiesterases to degrade cGMP. Upon 
expression of the cGMP degrading PDE5a, Cygnet-2.1 displays a fast dynamic 
response reflecting both cGMP binding and unbinding. During a second application of 
ANP, again the signal was fully reproducible. Although somewhat faster than during 
the first stimulation, similar amplitudes were reached during the second stimulation.  
Similar experiments were performed using calcium imaging. For these experiments, 
FlpTS GC-A cells were transiently transfected with PDE5a. After being loaded with 
Fluo-4 for 30 to 40 minutes, cells were transferred into the recording chamber and 
used for calcium imaging according to the protocol shown in Figure 3.1.7.  
The fluorescence intensity of two FlpTS GC-A cells was plotted over time (Figure 
3.1.8). The two cells display very different calcium changes. Cell 1 displayed a 
calcium response similar to those shown in Figure 3.1.1. The calcium concentration 
sharply increased upon stimulation with 1 nM ANP, and remained elevated upon 
washout. During the second period of ANP stimulation the cell barely responded. In 
contrast, cell 2 responded with transient calcium elevations to both ANP applications. 
The discrepancy between cell 1 and 2 can be explained by the low transfection 
efficacy. Most probably, cell 1 did not express PDE5a, while cell 2 did.  
Due to the low transfection efficiency, both PDE5a-expressing cells and 
none-PDE5a-expressing cells could be found in every recording. Among the whole 
population of the FlpTS GC-A cells recorded in this set of calcium-imaging 
experiments, about 42% of the cells (60/143) displayed permanent calcium elevations 
like cell 1, while 37% of the cells (53/143) displayed transient calcium elevations like 
cell 2. The remaining 21% cells (30/143) did not respond to ANP stimulation, 
probably due to a low expression of pGC-A.  
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Figure 3.1.8: cGMP degradation by PDE5a in FlpTS GC-A cells results in transient 
calcium signals upon ANP stimulation. 
The fluorescence signal of two FlpTS GC-A cells loaded with Fluo-4 is plotted over time. ANP (1 
nM) was applied during seconds 30 to 90 and 210 to 270. Cell 1 (probably without PDE5a) 
showed a rapid increase of the Fluo-4 fluorescence, indicating a rise in the intracellular calcium 
concentration upon the first stimulation with ANP. Its fluorescence remained elevated until the end 
of the recording. Cell 2 (probably expressing PDE5a) showed transient increases of the Fluo-4 
fluorescence, indicating transient elevation of the internal calcium concentration during the two 
applications of ANP.  
 
3.1.4 Selectivity of Cygnet-2.1  
In the following I tested whether the response of Cygnet-2.1 was specific for cGMP. 
The FlpTS GC-A cell line is a modified HEK-293 cell line and, therefore, expresses 
β-adrenergic receptors (βARs) (Krupinski et al., 1992). The βARs are linked to GS 
proteins which in turn couple to adenylate cyclases. Agonists like noradrenaline (NA) 
activate βARs and, thus, cause a rise in the intracellular concentration of cAMP. 
Therefore, the response of Cygnet-2.1 to cAMP was tested in FlpTS GC-A cells 
co-transfected with Cygnet-2.1 and PDE5a. One of the recordings is shown Figure 
3.1.9. 
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Figure 3.1.9: Cygnet-2.1 seems to respond to both cGMP and cAMP. 
The FRET change of four FlpTS GC-A cells transiently co-transfected with Cygnet-2.1 and 
PDE5a was plotted over time. ANP (1 nM) was applied from 30 to 90 seconds and from 510 to 
570 seconds. All cells showed transient FRET changes, indicating a transient elevation of the 
intracellular cGMP concentration during the application of ANP. NA (0.1 mM) was applied from 
270 to 330 seconds. During application, a FRET change was recorded in all four cells that was 
similar in amplitude to the FRET change during ANP application. This suggests that Cygnet-2.1 
responds to the increase in the internal cAMP concentration upon the stimulation with NA. After 
the washout of NA, an overshoot appears in all trances when the ratio recovers to the baseline.  
 
In Figure 3.1.9, the recordings of four cells co-expressing Cygnet-2.1 and PDE5a are 
shown. During seconds 30 to 90, ANP (1 nM) was applied. A transient FRET change 
was recorded, indicating a quick increase and decrease of cGMP concentration in all 
four cells. After a 3-minute washout, NA (0.1 mM) was applied between seconds 270 
and 330. Again, all four cells displayed transient FRET changes; however, the kinetics 
differed from those observed during ANP stimulation. ANP induced a sharp increase 
of the ratio CFP/YFP that was followed by a slow increase until the peak or a plateau 
was reached. Cells 3 and 4 did not reach a plateau during ANP application. In contrast, 
during NA application the peak was reached early followed by a plateau phase or even 
a decrease in the response. Furthermore, upon washout of NA, an overshoot was 
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always observed during which the ratio went below the baseline. After another 
3-minute wash, ANP (1 nM) was applied again for 1 minute. The transient FRET 
change showed the same shape as during the first application of ANP. 
Honda and his colleagues found that Cygnet-2.1 has a 500-fold higher affinity for 
cGMP than for cAMP (KD (cGMP) = 600 nM, KD (cAMP) = 300 µM; Honda et al., 
2005). However, in the experiments shown in Figure 3.1.9, 1 nM ANP and 0.1 mM 
NA induced a similar response of the sensor, indicating that Cygnet-2.1 responded to 
increases of both cGMP and cAMP. The FRET change during NA application was 
nearly as strong as that during ANP application but differed slightly in the time course. 
If one assumes that the affinity of Cygnet-2.1 for cAMP is several hundred fold lower 
than its affinity for cGMP, one must conclude that the cAMP concentration upon 
stimulation with NA is several hundred fold higher than the cGMP concentration 
induced by ANP stimulation. Under such circumstances, Cygnet-2.1 probably shows 
little selectivity between cGMP and cAMP. As the selectivity of the sensor is a very 
important issue, one must use this sensor with great caution. The conditions in which 
the sensor can be used will be discussed in detail in Chapter 4.1.  
Conclusion 
In this chapter, I have shown that Cygnet-2.1 is capable of detecting changes in the 
intracellular cGMP concentration in FlpTS GC-A cells in a time-resolved manner. The 
fluorescence intensity of CFP and YFP changed in a mirror reversed way upon ANP 
stimulation, which is a result of the changed FRET efficiency due to cGMP binding to 
the sensor. The increased ratio of CFP/YFP reflects an elevation of the intracellular 
cGMP concentration. The fast responses upon cGMP binding and unbinding facilitate 
the visualization of dynamic changes, which makes the sensor qualified for studying 
cGMP metabolism both in vitro and in vivo.  
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3.2 Retinal culture  
In my thesis I established different types of mouse primary retinal cultures. The aim 
was to use these cultures to establish virus mediated transduction and cGMP-imaging 
in vitro. 
The first type of culture is the retinal whole-mount culture. Retinae of young mice 
were cultured intact. The advantage of this culture is the good preservation of the 
retinal layers and cell types in vitro. However, as the retina remains intact the different 
retinal cell types are not equally well accessible for viral transduction. The second 
approach was to culture dissociated retinal cells. The advantage of dissociated cell 
cultures is that all cells are equally accessible. As a disadvantage cultured cells may 
differ substantially from their counterparts in vivo, because their environment is 
drastically changed. The culture of retinal slices is a compromise as the accessibility 
of cells is better than in the whole-mount culture and the environment is less disturbed 
than in dissociated cell cultures. The three types of retinal cultures will be evaluated 
in this chapter.  
3.2.1 Organotypic retinal whole-mount culture 
The retinal whole-mount cultures were performed in two different ways: as folded and 
as flattened cultures. In brief, retinae from mice at postnatal day 8 (P8) were carefully 
isolated and placed onto a culture membrane. For folded cultures, the retinae were 
allowed to fold according to their natural curvature when they were put onto the 
membrane. Thus, the ganglion cell layer was sandwiched in the middle, and the 
photoreceptors of the lower part of the folded tissue touched the membrane whereas 
the photoreceptors of the upper part were exposed to the air, only covered by a thin 
film of liquid (see Figure 2.5). To obtain flattened cultures, retinae were flattened with 
the photoreceptors attaching the membrane whereas the ganglion cell layer was 
directed towards the air-medium interface (see Figure 2.5). It was crucial to not 
submerse the cultures in the culture medium but to maintain both flattened and folded 
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cultures at the air-medium interface in order to preserve the native structures of the 
tissue.  
My aim was here to generate organotypic cultures that maintain native structures such 
as the typical retinal layering. When retinae from P8 mice are cultured, they are not 
yet fully mature at the day of cultivation. Therefore, it is also important to investigate 
whether retinae developed in vitro in a similar way as they do in vivo. These two 
aspects determine the quality of whole-mount cultures. To this end, both types of 
whole-mount cultures were characterized by cell type-specific immunochemical 
markers and compared to native retinae of the corresponding developmental stages. 
The results of my immunochemical studies are presented in the following figures 
(Figure 3.2.1 - Figure 3.2.6). 
In each figure, the upper row shows vertical sections through native retinae of 
different postnatal stages: P8, P10, P12, P16, P20, and P24. Vertical sections of folded 
cultures are shown in the middle row and vertical sections of flattened cultures are 
depicted in the lower row. All cultured retinae were explanted at P8 and fixed after 2, 
4, 8, 12, and 16 days of cultivation, respectively. Sections of native as well as cultured 
retinae were stained and analyzed by confocal laser scanning microscopy. The orange 
bars in the figures represent the position of the culture membrane and thus describe 
the orientation of the whole-mount during cultivation.  
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Figure 3.2.1: Recoverin label in vertical sections of native mouse retina and 
whole-mount retinal cultures.  
Upper row: native retinae of P8, P10, P12, P16, P20, and P24 mice. Middle row: whole-mount 
cultures in the folded condition, lower row: whole-mount cultures in the flattened condition at 2nd, 
4th, 8th, 12th, and 16th days of cultivation, respectively. All arrows mark recoverin-immunoreactive 
type 2 bipolar cells. The arrowheads in the upper row indicate the outer segments. Arrowheads in 
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the middle row indicate the degenerated ONL in the lower part of the cultures. Arrowheads in the 
lower row indicate neurites that can be traced from photoreceptors into the INL. Orange bars 
represent the membrane. The dotted lines divide the upper and the lower parts of the cultures in 
the folded conditions.  
Scale bar = 20 µm.  
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Figure 3.2.1 shows immunochemical stainings using antibodies against recoverin. 
Recoverin is a neuronal calcium-binding protein. In photoreceptors recoverin inhibits 
the rhodopsin kinase. Recoverin is a typical marker for both photoreceptor types but 
also for type 2 bipolar cells in the mouse retina (Dizhoor et al., 1991; Kawamura, 
1993; Milam et al., 1993; Haverkamp and Wässle, 2000). The control stainings of 
native vertical sections (upper row) showed recoverin immunoreactivity (recoverin-IR) 
within the entire outer nuclear layer (ONL), where the somata of photoreceptors are 
located. In addition, the inner segments (IS) and the outer segments (OS) that 
developed after P12 (arrowheads) were recoverin-positive. The thickness of the ONL 
was appr. 100 µm including 13 ~ 15 rows of photoreceptor somata and did not change 
much from P8 to P24. Within the inner nuclear layer (INL), type 2 bipolar cells were 
detectable by recoverin-IR from P10 on (arrows).  
In cultured retinae, the over-all structures were preserved under both folded and 
flattened conditions. However, degeneration was observed particularly in the part 
where the tissue had attached to the membrane. Degeneration was reflected by a 
reduced number of cells and a disturbed retinal organization.  
In folded cultures (middle row), the lower retinal tissue (below the dotted line) 
degenerated rapidly. The ONL already started to disintegrate after two days of 
cultivation (“Folded”, 2nd day, arrowheads) and degenerated further during the culture. 
After 16 days of cultivation, only few recoverin-positive cells remained in this part of 
the tissue (“Folded”, 16th day, arrowheads). In contrast, the upper retinal tissue (above 
the dotted line) seemed to be unaffected during the first 4 culturing days. The 
thickness of the ONL was similar to that of the native retina at the corresponding 
stage. From the 8th day of cultivation, the ONL became progressively thinner: 8 ~ 10 
rows of photoreceptor somata were observed on the 8th and 12th day in vitro, 6 ~ 8 
rows on the 16th day. The inner segments were always shorter in cultured rods than in 
native ones and the outer segments were not clearly observed even in the later period 
of cultivation. Type 2 bipolar cells were detected by recoverin staining from the 4th 
day of cultivation on (“Folded”, arrows). However, the axons of type 2 bipolar cells 
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became very short during the last stage of cultivation. Nevertheless, most of the 
general retinal morphology revealed with recoverin staining seemed to be conserved 
in the upper tissue part over 16 days of cultivation. 
In flattened retinal cultures (lower row), the photoreceptors were attached to the 
membrane while the ganglion cells were exposed to the air. For better comparison the 
sections are shown in the same orientation as sections through the native retinae. The 
ONL started to degenerate early after culturing. It had disintegrated and reduced its 
thickness to about 80 µm (Flattened, 2nd day) already after 2 days of cultivation. On 
the 16th day the ONL eventually was reduced to a thickness of about 50 µm, 
corresponding to approximately half the thickness of a native ONL in a mature retina 
(compare P24, upper row). Not only the ONL, but also the outer plexiform layer 
(OPL) seemed to degenerate. The OPL was not a straight line and the border between 
the ONL and the INL become wavy on the 2nd culturing day. Some photoreceptor 
neurites even grew into the INL after 6 days of cultivation (“Flattened”, 8th to 16th day, 
arrowheads). Nevertheless, recoverin-positive type 2 bipolar cells could be observed 
in the INL from the 4th day of cultivation on (“Flattened”, 4th to 16th day, arrows) and 
thus appeared at the same time as in folded cultures. 
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Figure 3.2.2: PKCα label in vertical sections of native mouse retina and 
whole-mount retinal cultures. 
Upper row: native retinae of P8, P10, P12, P16, P20, and P24 mice. Middle row: whole-mount 
cultures in the folded condition, lower row: whole-mount cultures in the flattened condition at 2nd, 
4th, 8th, 12th, and 16th days of cultivation, respectively. Arrowheads in the upper row mark few 
PKCα-immunoreactive amacrine cells in the native retina. Arrowheads in the middle row indicate  
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some misplaced rod bipolar cells in the upper part of the folded cultures. Arrows in the lower row 
mark some gaps among axon terminal systems, and arrowheads mark some misplaced rod bipolar 
cells in the flattened cultures. Orange bars represent the membrane. The dotted lines divide the 
upper and the lower parts of the cultures in the folded conditions. 
Scale bar = 20 µm. 
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With the next stainings I focused on bipolar cells, the downstream targets of 
photoreceptors in the vertical pathway. Among all types of bipolar cells, rod bipolar 
cells come with the highest density. Figure 3.2.2 shows vertical sections of both native 
retinae and whole-mount cultures that were stained with antibodies against protein 
kinase Cα (PKCα). PKCα is the typical marker for rod bipolar cells in the mouse 
retina (Negishi et al., 1988; Greferath et al., 1990). As is shown in the native retina 
(upper row), rod bipolar cell somata usually sit in the uppermost row of the INL, next 
to the OPL; and their axons terminate in the innermost sub-layer of the IPL. In 
addition to rod bipolar cells, few somata (arrowheads) were found in the inner part of 
the INL. These cells clearly differ in size, shape and localization from rod bipolar 
cells and can be classified as amacrine cells (Haverkamp and Wässle, 2000). The 
morphology of rod bipolar cells and their PKCα-immunoreactivity (PKCα-IR) did not 
change during development from P8 to P24. 
In the folded cultures (middle row), the upper parts (above the dotted line) displayed 
relatively well-arranged PKCα-positive rod bipolar cell bodies during the whole 
culturing period. The somata of rod bipolar cells were located in the uppermost layer 
of the INL; except for very few misplaced ones (arrowheads) that were identified by 
their axons and axon terminals. However, the axon terminals of rod bipolar cells 
seemed to degenerate slightly. After the first 4 days of cultivation, the axon terminal 
systems displayed more diffuse staining patterns. At the 16th culturing day, an overall 
shortening of the rod bipolar cells could be observed as the total thickness of INL plus 
IPL had been reduced by nearly 50% compared to native tissue at P24 (upper row). 
Again in the lower parts of the cultures (below the dotted line), a fast and strong 
degeneration was observed leading to a disorganized staining pattern. The number of 
PKCα-positive cells was rapidly reduced during culturing. After 8 days of cultivation 
nearly no PKCα-immunoreactive cells could be observed in the lower part.  
In the flattened retinal cultures, the somata of rod bipolar cells became progressively 
misplaced. After 2 days of cultivation, some misplaced somata (arrowheads) could be 
observed. At later stages the majority of the rod bipolar cell bodies moved to the inner 
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part of the INL. In addition, the number of PKCα-positive somata progressively 
decreased after 8 days of cultivation. Accordingly, some gaps (arrows) were found in 
the axon terminal system layer at the same time. Nevertheless, the axon terminal 
systems displayed staining patterns similar to that found in the upper part of the 
folded cultures (comparing “Folded”, middle row).  
In the both folded and flattened cultures, PKCα-IR in the axon of rod bipolar cell was 
weaker during the first 2 days of cultivation. Only somata, dendrites and axon 
terminals were strongly immunoreactive, while the axons were hardly visible in the 
PKCα-staining (“Folded” and “Flattened”, 2nd day). Starting from the 4th culturing day, 
PKCα-IR was observed throughout the entire bipolar cell.  
Another bipolar cell marker - calcium binding protein 5 (CaBP5) for type 3, type 5, 
and rod bipolar cells - was also used in immunochemistry. These types of bipolar cells 
were observed in both folded and flattened cultures (data not shown). 
Horizontal cells are interneurons that form lateral connections in the OPL. For mouse 
horizontal cells, the calcium binding protein (CaBP, also called calbindin) is a reliable 
marker (Röhrenbeck et al., 1987). In Figure 3.2.3, sections of native retinae and 
whole-mount cultures were immunochemically stained for CaBP. In the native retina 
(upper row), CaBP-immunoreactivity (CaBP-IR) was found in horizontal cells 
(arrows) whose somata and neurites were immunoreactive. In addition, amacrine cells 
(arrowheads) at the inner margin of the INL and displaced amacrine cells (arrowheads) 
in the ganglion cell layer (GCL) also showed CaBP-IR. Two labeled prominent strata 
in the IPL were formed by the dendrites of CaBP-positive amacrine cells. During 
maturation, CaBP-IR in horizontal cells was progressively increasing until P16, while 
CaBP-IR in amacrine cells and their dendritic strata was gradually decreasing (P8 ~ 
P24, upper row). All micrographs in Figure 3.2.3 were stained under identical 
conditions and scanned using the same microscope settings.  
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Figure 3.2.3: CaBP label in vertical sections of native mouse retina and 
whole-mount retinal cultures.  
Upper row: native retinae of P8, P10, P12, P16, P20, and P24 mice. Middle row: whole-mount 
cultures in the folded condition, lower row: whole-mount cultures in the flattened condition at 2nd, 
4th, 8th, 12th, and 16th days of cultivation, respectively. In the upper row, arrows indicate  
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CaBP-immunoreactive horizontal cells and arrowheads indicate CaBP-immunoreactive amacrine 
cells both in the INL and in the GCL. In the lower row, arrowheads indicate two horizontal cells 
misplaced to the ONL. Orange bars represent the membrane. The dotted lines divide the upper 
and the lower parts of the cultures in the folded conditions. 
Scale bar = 20 µm. 
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In folded culturing conditions (middle row), the staining in the upper part (above the 
dotted line) strongly resembled the staining in the native retinae. However, the 
staining seemed more diffuse. While under native conditions, CaBP-IR in horizontal 
cells increased with age, in the cultures no changes in CaBP expression in horizontal 
cells were observed during cultivation (compare to native retina at P8 to P24, upper 
row). On the other side, CaBP-positive amacrine cells showed a similar decrease in 
immunoreactivity as observed in native retina. In the lower part of the culture (below 
the dotted line), strong degeneration similar to that found in previous stainings (Figure 
3.2.1 & Figure 3.2.2) was observed.  
In the flattened cultures (lower row), the outer retina showed a certain degree of 
degeneration. The OPL became more wavy and in the later culturing stages, some 
horizontal cell bodies (“Flattened”, 12th day, arrowheads) were found misplaced to the 
ONL. In contrast, the staining pattern for CaBP-positive amacrine cells was 
surprisingly good. Amacrine cells in both the INL and the GCL and their strata in the 
IPL were well preserved even after 16 days in culture. Their CaBP expression was 
higher than in native retina (comparing P8 to P24, upper row).  
The following immunostainings will focus on certain types of amacrine cells that can 
be labeled with antibodies against calretinin during cultivation. Antibodies against 
calretinin do not only label many amacrine cells and ganglion cells, but also three 
characteristic strata in the IPL of the mouse retina. The outermost and innermost strata 
are identical to those stained by the CaBP antibodies (see Figure 3.2.3, upper row) and 
are formed by the dendrites of cholinergic amacrine cells (Haverkamp and Wässle, 
2000).  
Figure 3.2.4 shows vertical sections of native retinae and whole-mount retinal cultures, 
which were stained with antibodies against calretinin. Calretinin-immunoreactivity 
(calretinin-IR) was only found in the inner part of the retina. In native retinae (upper 
row), many somata in the INL and in the GCL and processes in the IPL were 
immunoreactive. In P8 retina, calretinin-IR was strongest in many big neurons (long 
arrows) in the GCL, but weaker in many neurons in the INL. Based on the large size 
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of the somata in the GCL, they are probably ganglion cells. Also bundles of ganglion 
cell axons (arrowheads) are positive for calretinin. In the IPL, strongest 
immunoreactivity was found in a thick continuous band. Starting from P10, there was 
a progressive increase in the number of strongly calretinin-immunoreactive amacrine 
cells (short arrows) in the INL and displaced amacrine cells (short arrows) in the GCL 
that have relatively small somata compared to the ganglion cells. Most notably, three 
distinct calretinin-positive strata (arrowheads) in the IPL developed.  
When the retinae were cultured in the folded condition (middle row), the 
calretinin-positive amacrine cells degenerated strongly not only in the lower, but also 
in the upper part of the cultures. During the first 2 days of cultivation, the number of 
calretinin-positive cells in the GCL was greatly reduced, while the amacrine cells in 
the INL seemed to survive better. In the IPL, the staining pattern was less clear than in 
native retina. On the 16th culturing day, only one calretinin-positive band was 
observed in the IPL near the border to the INL.  
In contrast, in flattened retinal cultures (lower row), calretinin-immunoreactive 
amacrine cells seemed to be well preserved. In addition, three calretinin-positive 
strata in the IPL were recognized even after 16 days in vitro (arrowheads), except that 
the middle stratum was weaker than the other two.  
In addition to calretinin, stainings (data not shown) with antibodies against glutamic 
acid decarboxylase (GAD, including GAD65 & GAD67), glycine transporter 1 
(GlyT1) and tyrosine hydroxylase (TH) revealed GABAergic amacrine cells, 
glycinergic amacrine cells and dopaminergic amacrine cells (Nguyen-Legros et al., 
1997; Haverkamp and Wässle, 2000), respectively. All these types of amacrine cells 
could be identified in both types of whole-mount cultures. These stainings 
corroborated the finding that the inner retina including IPL and GCL degenerated fast 
in the folded cultures while it was better preserved in the flattened cultures. 
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The health status of nerve tissue can also be determined by the properties of the 
neuron supporting cells, glia cells. Upon injury or during degeneration, often, glia 
cells become activated.  
 
 
Figure 3.2.4: Calretinin label in vertical sections of native mouse retina and 
whole-mount retinal cultures.  
Upper row: native retinae of P8, P10, P12, P16, P20, and P24 mice. Middle row: whole-mount 
cultures in the folded condition, lower row: whole-mount cultures in the flattened condition at 2nd, 
4th, 8th, 12th, and 16th days of cultivation, respectively. All arrowheads indicate the three distinct  
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In the retina, three types of glia cells are found: astrocytes can be stained by 
antibodies against glial fibrillary acidic protein (GFAP). Müller cells and microglia 
are negative for GFAP. Under neurodegenerative conditions however, Müller cells  
 
 
strata in the IPL. In the upper row, long arrows indicate immunoreactive ganglion cells in the 
GCL from P8 retina and the short arrows indicate immunoreactive amacrine cells both in the INL 
and in the GCL. Orange bars represent the membrane. The dotted lines divide the upper and the 
lower parts of the cultures in the folded conditions. 
Scale bar = 20 µm. 
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express GFAP. Figure 3.2.5 shows sections labeled for GFAP from native retina and 
from whole-mount cultures. GFAP-immunoreactivity (GFAP-IR) in the native retina 
(upper row) was strong in astrocytes that are mainly found in the nerve fiber layer 
(NFL) and sometimes in the GCL. Arrows indicate some blood vessels that were 
stained by the secondary antibody against mouse primary antibodies. Müller cells 
expressed little or no GFAP at all. In cultured retinae, GFAP expression was 
immediately up-regulated, independent of the culturing conditions. In both folded and 
flattened cultures (middle row & lower row), GFAP-IR was initially enhanced in the 
NFL after 2 days of cultivation. Then, fibers running vertically through the retina 
towards the ONL became strongly GFAP-immunoreactive. These fibers are Müller 
cell processes. On the 8th days of cultivation, GFAP seemed to be fully expressed. 
Müller cells remained GFAP-immunoreactive throughout the entire culturing time. 
Strangely, in the lower part of the folded culture, GFAP-IR was much weaker and the 
onset of GFAP expression seemed to be delayed. As is known from previous stainings 
(Figure 3.2.1 - Figure 3.2.4), the lower part degenerated very rapidly in culture. 
Probably, GFAP expression could be up-regulated only when the retinal tissue was 
still preserved and maintained. Thus, the lower part of the folded cultures might 
degenerate too fast for Müller cells to become reactive and express GFAP. From day 
12 on, GFAP-IR was also found in the lower part.  
In this project, the main research interests are focused on the NO-cGMP pathway in 
the mouse retina. NO is synthesized by NO-synthase (NOS). Amacrine cells 
containing NOS and releasing NO are found in the mouse retina. Hence, it was 
important to know whether NOS-immunoreactive cells were also found in 
whole-mount cultures and if NOS-positive cells retained their typical morphology.  
Figure 3.2.6 shows the stainings with antibodies against NOS. In the native tissue 
(upper row), NOS-immunoreactivity (NOS-IR) was found only in amacrine cells. 
Two types of NOS-amacrine cells were identified. One type (arrows) with strong 
immunoreactivity had a large elongated soma and one thick primary neurite ramifying 
around the middle of the IPL. This type of NOS-positive cells was present in all 
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postnatal stages (P8 to P24) of the native retina. Another type of NOS cells (arrow 
heads) was small in size and situated very close to the border of the IPL. This cell 
type only became weakly immunoreactive after P10. Starting from P12, many 
processes throughout the entire thickness of the IPL were visible in the staining. The 
processes observed only at the later stages might arise from the small NOS-amacrine 
cells. Both types of cells can be found in the INL and the GCL. However, the 
NOS-immunoreactive amacrine cells represent only a small population of amacrine 
cells. 
NOS-IR was also found in amacrine cells in both folded and flattened whole-mount 
cultures. As mentioned above, the inner retina degenerated faster in the folded 
culturing conditions while it could be preserved longer in the flattened culturing 
conditions. Thus, not surprisingly in the upper part of folded cultures (middle row), 
NOS-staining appeared degenerated. The sparse NOS-immunoreactive processes in 
the IPL and the number of cells continuously lessened after explanting the retina.  
NOS-amacrine cells in the flattened cultured retinae (lower row) were preserved, 
which was expected according to the previous results from calretinin-staining. Two 
days after explanting, the inner retina showed a similar NOS-staining pattern as the 
native retina of a P10 mouse. After the 8th culturing day, many NOS-immunoreactive 
interlaced processes through the entire IPL were observed. Both types of 
NOS-amacrine cells were observed during all culturing stages in the flattened cultures. 
However, the number of displaced NOS-amacrine cells in the GCL strongly decreased 
while the number of NOS-amacrine cells in the INL seemed to increase.  
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Figure 3.2.5: GFAP label in vertical sections of native mouse retina and 
whole-mount retinal cultures.  
Upper row: native retinae of P8, P10, P12, P16, P20, and P24 mice. Middle row: whole-mount 
cultures in the folded condition, lower row: whole-mount cultures in the flattened condition at 2nd, 
4th, 8th, 12th, and 16th days of cultivation, respectively. The arrowheads in the upper row indicate  
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blood vessels stained by the secondary antibody against mouse primary antibodies. Orange bars 
represent the membrane. The dotted lines divide the upper and the lower parts of the cultures in 
the folded conditions. 
Scale bar = 20 µm. 
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Figure 3.2.6: Nitric oxide synthase label in vertical sections of native mouse retina 
and whole-mount retinal cultures.  
Upper row: native retinae of P8, P10, P12, P16, P20, and P24 mice. Middle row: whole-mount 
cultures in the folded condition, lower row: whole-mount cultures in the flattened condition at 2nd, 
4th, 8th, 12th, and 16th days of cultivation, respectively. In the upper row, arrows indicate strongly  
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immunoreactive amacrine cells with large somata; and arrowheads indicate weakly 
immunoreactive amacrine cells with small stomata. Orange bars represent the membrane. The 
dotted lines divide the upper and the lower parts of the cultures in the folded conditions. 
Scale bar = 20 µm. 
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Conclusion for organotypic retinal whole-mount cultures 
The way the retina is placed on the culture membrane strongly affects the survival of 
the retina and its development during cultivation. When the retina is folded according 
to its natural curvature, the lower part degenerates rapidly. The upper part of the tissue 
facing the air-medium interface can be cultured longer. In the upper part, ONL, OPL 
and INL develop structures similar to those found in vivo. However, the inner part of 
the upper cultures, especially the GCL and the ON-sublayers of the IPL, degenerates 
much faster. In flat-mounted retinal cultures with photoreceptors attaching membrane, 
the outer parts of the retina including the ONL, the OPL and the outer margin of the 
INL start to degenerate rapidly, while the inner parts including the inner margin of the 
INL, the IPL and the GCL appear better preserved during cultivation. For experiments 
that focus on the bipolar cells and their synaptic connection with photoreceptors, it is 
suggested to use the folded culture method. However, if experiments aim to 
investigate processes in the IPL and the GCL, the flattened culture method is the 
better choice. As in both types of whole-mount cultures morphological and 
immunoreactive features of cells are best retained between the 4th and 8th culturing 
day, this time window is suggested for experiments. 
Generally after 8 days in vitro, cultures show some kind of degeneration. Therefore, in 
either folded or flattened culturing condition, it is strongly suggested that cultivation 
does not exceed 8 days.  
3.2.2 Dissociated retinal cell culture  
Retinae from young mice between P2 to P4 were used for the dissociated retinal 
cultures. Upon isolation from the eyecup, the retinae were incubated with papain and 
cells were dissociated by trituration. Cells were seeded onto pre-coated coverslips and 
cultured for up to 4 weeks. Cultures between the 8th and the 14th day of cultivation 
were characterized by reliable immunomarkers for different retinal cell types. The 
results are presented in this chapter.  
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Markers were chosen to cover as many retinal cell types as possible: recoverin for 
photoreceptors; CaBP for horizontal cells; synaptotagmin-2 (Syt2), CaBP5, and PKCα 
for bipolar cells; GAD67 and GlyT1 for amacrine cells, and GFAP for glia cells. In 
dissociated cultures, the environment of the cells differs strongly from the native 
conditions. Therefore, cells will differ morphologically from their counterparts in the 
intact retina. Moreover, it cannot be ruled out that some markers might yield different 
staining patterns than in the intact retina.   
Figure 3.2.7 displays one retinal culture triple-stained with antibodies against 
recoverin, rhodopsin, and blue opsin. As shown in Figure 3.2.1, recoverin is expressed 
mainly in photoreceptors and also in type 2 bipolar cells in the mouse retina. In panel 
A, many recoverin-positive cell bodies and their neurites were revealed. Most of them 
resemble mouse photoreceptors as they have relatively small somata (6 to 7 µm in 
diameter). In some cells, the somata were stained inhomogeneously by the recoverin 
antibodies (appearing as unstained “bubbles”, arrowheads in the inserted figure of 
panel A), which is a characteristic of the recoverin staining for cultured 
photoreceptors. Moreover, in contrast to other neurons found in the cultures, the small 
recoverin-positive cells grew only few fine neurites with a maximum length of 45 µm. 
The very specific markers rhodopsin for rods and blue opsin for early developing 
cones are shown in panel B and C, respectively. Rhodopsin and opsin are usually 
expressed in the outer segments of either type of photoreceptors. Surprisingly, while 
rhodopsin-immunoreactivity (rhodopsin-IR) and blue opsin-immunoreactivity (blue 
opsin-IR) were found in few cells, the majority of the recoverin-positive cells were 
not labeled by these markers. Only one cell (red arrows) in panel B displayed 
rhodopsin-IR and two cells (blue arrows) in panel D exhibited blue opsin-IR. 
Furthermore, the outer segments cannot be identified in cells of dissociated cultures. 
These results suggest that many photoreceptors did not develop outer segments and 
stopped expressing rhodopsin or opsin, respectively, during culturing. Therefore, in 
dissociated cultures photoreceptors can only be identified based on the morphology 
(small cell body, one or few short neurites) and recoverin-IR. 
75 
 
Results 
In addition, recoverin-positive cells with larger soma size (around 8 to 9 µm in 
diameter, white arrows in panel A), were observed in this kind of culture. These 
bigger cells might represent type 2 bipolar cells according to the size and their 
recoverin-IR. However, these cells do not always display a clear bipolar morphology.  
 
 
Figure 3.2.7: Identification of photoreceptors in dissociated retinal cultures.  
Dissociated retinal cultures were stained with immunochemical markers for recoverin (green), 
rhodopsin (red), and blue opsin (blue). The inserted panel is a higher magnification of the marked 
area of panel A. White arrowheads mark the “bubbles” in the photoreceptor somata and white 
arrows mark cells that are presumably type 2 bipolar cells. Rhodopsin-immunoreactive cells and 
blue opsin-immunoreactive cells are indicated by a red arrow and blue arrows respectively.  
Scale bar = 20 µm.  
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Figure 3.2.8 focuses on neurons postsynaptic to photoreceptors in the native retina: 
horizontal cells and bipolar cells. Immunochemical staining for CaBP on a dissociated 
culture is shown in panel A. As shown in Figure 3.2.2, strong CaBP-IR is a reliable 
marker for horizontal cells. Figure 3.2.8 A shows a strongly stained cell with a large 
soma (~15 µm in diameter, arrow). Some thick projections (arrowheads) grow out and 
further bifurcate into many fine processes that spread widely in the surrounding area. 
Actually, only a part of the dendritic tree is displayed here. Normally, these branches 
extend to several hundred micrometers. These features agree with the morphology of 
horizontal cells in vivo forming far reaching lateral connections (Peichl and 
Gonzalez-Soriano, 1994). Moreover, the CaBP-immunoreactive cells were rare in the 
cultures, which agrees well with the relatively small number of horizontal cells in the 
retina. However, CaBP expression is also found in amacrine cells (see Figure 3.2.4) 
identified as cholinergic amacrine cells (Haverkamp and Wässle, 2000). To rule out 
that the CaBP-positive cells in the cultures were amacrine cells, a double-staining was 
performed. The staining for calretinin that is found in many amacrine cells including 
cholinergic amacrine cells is shown in red in the overlay (panel B). One strong 
calretinin-immunoreactive cell (red, long arrow) was found on the right to the 
CaBP-positive cell (green, short arrow). Clearly, there is no colocalization of the two 
markers. Therefore, the cells with CaBP-IR are identified as horizontal cells in 
dissociated cultures.  
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Figure 3.2.8: Identification of horizontal cells and bipolar cells in dissociated 
retinal cultures. 
Dissociated retinal cultures were stained with antibodies against CaBP (A & B, green), calretinin 
(B, red), Syt2 (C, D, E & F, red), recoverin (D, green) and vGlut1 (F, green). A & B: Short arrows 
indicate CaBP-immunoreactive somata. Arrowheads indicate CaBP-immunoreactive thick 
neurites. Long arrow indicates calretinin-immunoreactive soma. C, D, E & F: Short arrows 
indicate Syt2- immunoreactive somata. Long arrow indicates a big recoverin-immunoreactive cell. 
Arrowheads indicate neurites co-stained by antibodies against Syt2 and vGlut1. 
Scale bar = 20 µm.  
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Surprisingly, some antibodies used in native mouse retina as reliable bipolar cell 
marker such as PKCα for rod bipolar cells and CaBP5 for type 3, 5, and rod bipolar 
cells showed weak or variable stainings in the dissociated cultures. PKCα-IR was 
barely found in the cultures, while the immunoreactivity for CaBP5 was very faint 
(data not shown). The antibodies against the synaptic vesicle associated protein 
synaptotagmin-2 (Syt2) shows strong stainings. Syt2 was reported to be expressed in 
type 2 and 6 bipolar cell axon terminal systems and also horizontal cell terminals in 
the mouse retina (Fox and Sanes, 2007; Wässle et al., 2009). Using Syt2 antibodies, 
two kinds of cells were stained. Wide-field cells with big somata (about 15 µm in 
diameter) and very long neurites were found (data not shown). They were very rare. 
All three features indicate that they were horizontal cells. Double-staining of Syt2 
with the horizontal cell marker CaBP was not possible as both antibodies were raised 
in mouse. The more commonly found Syt2-positive cells might be bipolar cells. A 
Syt2 immunoreactive cell is shown in Figure 3.2.8 C. Its neurites are strongly 
immunoreactive. While from the morphology this cell does not appear bipolar at all, 
two morphological features indicate that this cell might be a bipolar cell rather than a 
horizontal cell. First, the soma is quite small (arrow, only about 8 µm in diameter). 
Second, the neurites are quite short (about 80 µm in radius), which is clearly much 
shorter than the projections from the horizontal cell in panel A. Most of the 
Syt2-positive cells found in dissociated cultures had similar features as the one shown 
in Figure 3.2.8 C. In Figure 3.2.8 D, no cell was co-stained in the double-labeling for 
recoverin and for Syt2. The larger recoverin-positive cell (long arrow) does not appear 
to be Syt2-IR. As this cell is much larger than a photoreceptor, it might represent a 
type 2 bipolar cells (compare Figure 3.2.1 & Figure 3.2.7) and hence, should be 
Syt2-positive (Haverkamp and Wässle, 2000; Wässle et al., 2009). One might 
conclude that either type 2 bipolar cells cease to express Syt2 in dissociated cultures, 
or, alternatively, that cells other than photoreceptors and type 2 bipolar cells express 
recoverin in dissociated cultures. Double-labeling using antibodies against Syt2 and 
against the vesicular glutamate transporter 1 (vGlut1) was performed to confirm that 
the small Syt2-positive cells were bipolar cells. vGlut1 is expressed in photoreceptor 
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terminals and bipolar cell axon terminals in the mouse retina (Haverkamp et al., 2003). 
Figure 3.2.8 E shows four small-field cells with Syt2-IR, whose somata are indicated 
by arrows. In the overlay F, co-expression of Syt2 and vGlut1 can be observed. The 
neurites (arrowheads) appear yellow due to the co-staining. Therefore, the small-field 
Syt2 immunoreactive cells probably are type 6 bipolar cells. But not all of them were 
found to be vGlut1-immunoreactive (data not shown), which might imply some type 6 
bipolar cells cease to express vGlut1 in dissociated cultivation.  
As a summary for cultured bipolar cells, their morphology mostly remodeled into 
multipolar forms and their functional properties also showed variable changes  
Figure 3.2.9 mainly focuses on different amacrine cell markers (panel A ~ C). 
Amacrine cells are the inhibitory interneurons in the retina. They can be further 
divided into many subtypes according to their neurotransmitters and molecular 
components. The two major neurotransmitters are γ-aminobutyric acid (GABA) and 
glycine. GABAergic and glycinergic amacrine cells each represent 40 to 50% of the 
whole amacrine cell population in the mouse retina (Marc, 1988; Pourcho, 1996; 
Nguyen-Legros et al., 1997; Pow and Hendrickson, 1999; Lin and Masland, 2006). 
The key enzyme that catalyzes the decarboxylation of glutamate to GABA and CO2 in 
GABAergic neurons is glutamic acid decarboxylase (GAD). In this study, an antibody 
against glutamic acid decarboxylase isoform 67 (GAD67) was selected as a marker 
for GABAergic amacrine cells. In panel A of Figure 3.2.9, some cell bodies (arrows) 
are immunoreactive for GAD67. Their somata had diameters of 10 to 12 µm, similar 
to the size of amacrine cells. Also numerous far reaching GAD67-immunoreactive 
processes can be observed. In the native retina, GABAergic amacrine cells are 
wide-field amacrine cells (Vaney, 1990; MacNeil and Masland, 1998; Lin and 
Masland, 2006), which agrees well with the morphology of GAD67-immunoreactive 
cells in the dissociated cultures. Thus, I consider all these GAD67-positive cells as 
GABAergic amacrine cells.    
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Figure 3.2.9: Identification of amacrine cells and glia cells in dissociated retinal 
cultures. 
Dissociated retinal cultures were stained with immunochemical markers for GAD67 (A, red), 
GlyT1 (B, green), NOS (C, cyan) and GFAP (D, yellow). All immunoreactive somata are marked 
with arrows.  
Scale bar = 20 µm. 
 
Another major group of amacrine is glycinergic. These cells can be labeled with 
antibodies against glycine or against the glycine transporter (Menger et al., 1998; Pow 
and Hendrickson, 1999; Haverkamp and Wässle, 2000). Therefore, the antibody 
against the glycine transporter 1 (GlyT1) was used to identify glycinergic amacrine 
cells. Figure 3.2.9 B shows four GlyT1-immunoreactive cells with their somata 
(arrows) and neurites. The staining appears membrane-associated, which was 
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expected as glycine transporters are located in the membrane of glycinergic cells. The 
GlyT1-positive processes are clearly shorter than the neurites of the GABAergic 
amacrine cells. The longest neurites of these glycinergic cells were about ~50 µm in 
length. In the mammalian retina, glycinergic amacrine cells are mostly small-field 
amacrine cells (Pourcho and Goebel, 1985; Menger et al., 1998). Therefore, the 
features of these cultured cells in panel B fit to those of glycinergic amacrine cells.  
Figure 3.2.9 C shows a staining with an antibody against NO-synthase (NOS). In 
agreement with the rather small population of NOS-positive amacrine cells in vivo, 
the number of NOS-positive cells in dissociated retinal cultures was also found to be 
relatively small. In this panel, one cell shows strong immunoreactivity in its cell body 
and neurites. Although there are two types of NOS-positive amacrine cells in the 
native retina as shown in Figure 3.2.6, only one type was found in the dissociated 
cultures, which has a big soma (arrow) and neurites extending several hundred 
micrometers.  
Panel D of Figure 3.2.9 shows a culture stained for GFAP. It was observed that glia 
cells were important in all dissociated retinal cultures. Glia cells grew below the 
cultured neurons and formed a homogenous cellular support for them. The dissociated 
retinal neurons survived only on this layer of glia cells. Glia cells were found all over 
the cover slips. In contrast, GFAP-IR is surprisingly rarely found in the dissociated 
cultures. In Figure 3.2.9 D, two glia cells (arrows) exhibit GFAP-IR. In the normal 
healthy retina, only astrocytes express GFAP. The cells with GFAP-IR might be 
astrocytes. Antibodies against glutamine synthetase (GS), a specific marker for Müller 
cells (Linser et al., 1984), did not reveal immunoreactive cells (data not shown). The 
unstained glia cells might be Müller cells whose expression pattern has changed due 
to the culturing conditions. 
Conclusion for dissociated retinal cell cultures 
The dissociated mouse retinal culture was established successfully. Retinal neurons 
could survive for more than 4 weeks on coated coverslips in vitro. However, the 
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number of cultured cells decreased with the duration of the culture. Therefore, the best 
time window for experiments on these cultures would be from the 2nd day after 
seeding until the 14th day. Photoreceptors, horizontal cells, bipolar cells, and amacrine 
cells were identified in cultures, although some types of cells appeared to differ 
morphologically from their counterparts in vivo. The heterogeneous population 
indicated a good quality of the cultures. Furthermore, the present of NO-positive cells 
might offer an additional platform for investigations of the NO-cGMP pathway in 
these retinal cultures.  
3.2.3 Organotypic retinal slice culture 
The third type of retinal culture can be considered as a compromise: it makes the 
retinal neurons similarly accessible as in the dissociated culture while attempting to 
preserve the retinal structure as much as possible.   
For this type of culture, isolated retinae from P8 mice were sliced and slices were 
cultured up to 8 days. Slices were sectioned at a minimum thickness of 150 μm and a 
maximum thickness of 250 μm. Cultures were characterized by the same 
immunochemical markers as described for other culture types.  
Generally spoken, the retinal architecture was not well retained in the slice cultures. 
Immunochemical studies on 150 μm retinal slices are shown in Figure 3.2.10. The 
recoverin-label in the first row indicate the changes of photoreceptors: photoreceptors 
were initially found in a limited area during the first four days of culturing (Figure 
3.2.10, recoverin, 2nd & 4th day) but then grew into a loose pattern (Figure 3.2.10, 
recoverin, 6th & 8th day). The second row shows PKCα-staining. No PKCα-IR was 
observed in the first 4 days after seeding (Figure 3.2.10, PKCα, 2nd & 4th day). This is 
most surprising, as strong PKCα-IR is found in the retina at P8 (see Figure 3.2.2) the 
stage that was chosen for cultivation. From the 6th day on, PKCα-IR was found 
weakly in some cells but became more prominent on the 8th day. The calretinin 
staining in the third row shows amacrine cells with large somata and long neurites in 
all stages of cultivation. However, no structure was observed that reminded of an IPL,  
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Figure 3.2.10: Immunochemical characterization of 150 μm-thick retinal slice 
cultures.  
150 μm-thick retinal slice cultures at 2nd, 4th, 6th and 8th days of cultivation were immunostained  
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with antibodies against recoverin (first row, green), PKCα (second 
row, red), calretinin (third row, yellow) and GFAP (bottom row, cyan).  
Scale bar = 20 µm. 
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Figure 3.2.11: Immunochemical characterization of 250 μm-thick retinal slice 
cultures.  
250 μm-thick retinal slice cultures at 2nd, 4th, 6th and 8th days of cultivation were immunostained 
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with antibodies against recoverin (first row, green), PKCα (second 
row, red), calretinin (third row, yellow) and GFAP (bottom row, cyan).  
Scale bar = 20 µm 
  
87 
 
Results 
not to mention three distinct calretinin-immunoreactive bands. The last row of 
GFAP-staining shows strong immunoreactive fibers in all stages. 
Increasing the thickness of the retinal slices to 250 μm did not improve the tissue 
preservation (Figure 3.2.11). Many disorganized photoreceptors were found in the 
recoverin-staining in all periods of culturing (first row). Again, PKCα expression was 
delayed (second row). Amacrine cells visualized using calretinin-staining showed 
unorganized distribution during the whole culturing period (third row). Strangely, two 
days after seeding, GFAP was not expressed as strongly as it was found in 150 μm 
s1ice cultures. GFAP-IR increased from the 4th day of culturing. 
Conclusion for organotypic retinal slice cultures 
The overall results indicated an extremely fast degeneration of the retina structure in 
retinal slice cultures, which was independent of the original thickness of the slice. 
Besides, the properties of some types of cells were also changed. For example, rod 
bipolar cells could temporarily stop synthesizing PKCα when the culturing was 
initiated. Therefore, the sliced retinae are not able to preserve native structures in 
culture. So this type of cultures is not suggested for further experiments that require a 
well preserved retinal network.  
 
3.3 AAV-mediated transduction in vitro  
3.3.1 AAV-mediated transduction in dissociated retinal cell cultures 
In this project, adeno-associated viruses (AAVs) were used as gene ferry to introduce 
foreign genes into retinal neurons. Seven different serotypes of AAVs were available: 
AAV1, AAV2, AAV4, AAV5, AAV6, AAV8, and AAV9. Different serotypes have been 
shown to have different transduction efficiency for different cell types. The selectivity 
of these viruses is most probably due to the receptor-mediated endocytosis of the 
target cells (Michelfelder and Trepel, 2009; Agbandje-McKenna and Kleinschmidt, 
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2011). To evaluate the transduction efficiency on retinal cells, AAVs were used, which 
carry the cDNA for the enhanced green fluorescent protein (GFP; AAVs-GFP) under 
the control of a cytomegalovirus (CMV) promoter. Usually two days after seeding, 
viruses were added directly into the culture medium of dissociated retinal cultures. 
Cells were cultured for another 6 to 8 days before being fixed and analyzed by 
immunocytochemistry.  
For the initial testing, TO-PRO3 was used to stain nuclei for cell counting. Figure 
3.3.1 gives an overview on the transduction efficiency for different serotypes of AAVs. 
To enable a better comparison of the strength of expression, GFP was not visualized 
via immunocytochemistry using antibodies against GFP. Rather, the endogenous 
fluorescence of GFP was detected in all transduction experiments using the same 
settings of the microscope. The total number of cells in the same field is shown by the 
nuclear stain in blue. The overlays reveal the transduction rate of the seven different 
AAV serotypes in the cultures.  
In dissociated cultures transduced by AAV1-GFP (Figure 3.3.1, A1 - A3), GFP 
expression was found in many cells. A few cells showed large somata (arrows) while 
the rest of the cells were smaller in size. The intensity of the green fluorescence 
differed from one cell to another. In the most intensely fluorescing cells, also the thick 
neurites (arrowheads) protruding from the soma could be observed. A similar 
expression pattern was found in AAV2-GFP infected cultures (Figure 3.3.1, B1 - B3). 
For example, two bright cells (arrows) are found in panel B1 together with several 
small cells, some of which have bright fluorescence and some of which are faint. In 
cultures incubated with AAV4-GFP (Figure 3.3.1, C1 - C3), only cells with small cell 
bodies were transduced. No larger cell was found that expressed GFP. AAV5-GFP 
(Figure 3.3.1, D1 - D3) gave the lowest transduction efficiency. Only few cells 
expressed GFP at a very low level as seen in D1. Based on this observation, AAV5 
was omitted from further tests.  
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Figure 3.3.1: GFP expression in dissociated retinal cultures upon transduction by 
AAVs. 
Dissociated retinal cultures were transduced by AAV1-GFP (A1 - A3), AAV2-GFP (B1 - B3), 
AAV4-GFP (C1 - C3), AAV5-GFP (D1 - D3), AAV6-GFP (E1 - E3), AAV8-GFP (F1 - F3), and  
90 
 
Results 
 
AAV9-GFP (G1 – G3). The green fluorescence represents endogenous GFP fluorescence. Cell 
nuclei were stained by TO-PRO3 (blue). All arrows indicate large neurons expressing 
GFP. Arrowheads indicate neurites. 
Scale bar = 20 µm 
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The infection pattern of AAV6-GFP (Figure 3.3.1, E1 - E3) was similar to that found 
in AAV1- and AAV2-infected cultures. In Figure 3.3.1 E1, two big cells (arrows) and 
a few small cells can be observed. Many of them have high GFP intensity reflecting a 
high expression level. In cultures transduced by AAV8 (Figure 3.3.1, F1 - F3) and 
AAV9 (Figure 3.3.1, G1 - G3) only few cells expressed GFP. However, these cells 
were usually large in size and had high expression levels. Additionally, 
GFP-expressing glia cells were found in all AAV-transduced cultures (data not 
shown). 
In general, all AAV serotypes transduced retinal neurons in dissociated cultures. 
However, different AAV serotypes yielded different transduction patterns and 
expression levels. As dissociated retinal cultures comprise a large variety of neuronal 
types, the transduction efficiency should not be determined simply on the percentage 
of transduced cells. In the following experiments, transduced cultures were 
counterstained with cell type specific markers.  
Figure 3.3.2 compares the detection of GFP based on its endogenous fluorescence 
(green, A) and on the immunocytochemical staining using antibodies against GFP (red, 
B). The number of cells that can be detected using immunocytochemistry is larger 
than the number of cells that are visualized by endogenous GFP fluorescence. Some 
cells that can barely be detected based on the endogenous GFP fluorescence are 
marked by arrowheads. The advantage of the immunocytochemical detection is 
twofold: it reveals cells with low expression level and it visualizes neurites. This 
finding was observed in all transductions independent of the AAV serotype. There are 
two possible reasons for this difference. First, due to the amplification step in indirect 
immunochemistry, several fluorescent molecules bind via secondary antibodies to 
each GFP molecule, resulting in a superior sensitivity of this method compared to the 
detection of endogenous fluorescence. Second, however, it cannot be ruled out that 
some GFP molecules are not functional and, therefore, do not emit fluorescence but 
can be detected by antibodies. Thus, immunolabeling with antibodies against GFP 
was employed for cell type identification.  
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Figure 3.3.2: Comparison of immunostaining for GFP with GFP fluorescence.  
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in red. The 
green fluorescence represents endogenous GFP fluorescence. Arrowheads indicate cells that show 
strong GFP-IR, but low GFP fluorescence. 
Scale bar = 20 µm.   
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In the following figures, counterstainings were performed systematically that covered 
nearly all neuronal types except for ganglion cells using reliable markers: recoverin 
for photoreceptors, CaBP for horizontal cells, Syt2 for type 6 bipolar cells, GlyT1 for 
glycinergic amacrine cells, GAD67 for GABAergic amacrine cells and NOS for NOS 
amacrine cells.  
Figure 3.3.3 gives an example of the cultures transduced by AAV2-GFP showing a 
double staining with antibodies against GFP in green and recoverin, the photoreceptor 
marker, in red. Prominent GFP expression was found in two cells with big somata and 
weaker expression was observed in many smaller cells (Figure 3.3.3 A). In the 
recoverin-staining many cells with small cell bodies were observed (Figure 3.3.3 B). 
In the overlay (Figure 3.3.3 C), the double-labelled small cells in yellow (arrows) can 
be identified as photoreceptors based on their recoverin immunoreactivity. But not all 
the recoverin-positive cells were infected. On average only about 10% (16/156) of the 
recoverin-immunoreactive cells were transduced by AAV2. On the other side, there 
were green cells that were negative for recoverin, which implies that AAV2 not only 
infects photoreceptors but also other types of retinal neurons. 
For better comparison, the following counterstainings shown in this section were all 
taken from cultures infected by AAV2-GFP. The results of the remaining AAV 
serotypes will be presented in Table 3.3.1. 
The double-staining for anti-GFP in green and CaBP in red is shown in Figure 3.3.4. 
In the anti-GFP micrograph (Figure 3.3.4 A), several cells show GFP expression upon 
AAV2-GFP transduction. In particular, two cells with big somata (arrows) are strongly 
immunoreactive for GFP. In the CaBP-staining (Figure 3.3.4 B), these two cells 
(arrows) are also visible, resulting in a yellow appearance in the overlay (Figure 3.3.4 
C). The statistical analysis from independent cultures yielded a transduction rate of 
100% (55/55) for CaBP-positive cells. AAV2 seems to be quite efficient to target large 
retinal neurons with CaBP-IR, most likely horizontal cells.  
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Figure 3.3.3: Identification of photoreceptors in AAV2-GFP transduced cultures. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for recoverin in red. Arrows indicate infected cells immunoreactive for recoverin.  
Scale bar = 20 µm.  
97 
 
Results 
 
Figure 3.3.4: Identification of horizontal cells in AAV2-GFP transduced cultures. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for CaBP in red to identify horizontal cells. Arrows indicate infected cells immunoreactive for 
CaBP.  
Scale bar = 20 µm.  
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Figure 3.3.5: Identification of type 6 bipolar cells in AAV2-GFP transduced 
cultures. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for Syt2 in red. Arrows indicate infected cells immunoreactive for Syt2. Two lower panels show 
higher magnifications of the marked area. Arrowheads indicate neurites of the cell. 
Scale bar = 20 µm. 
 
The type 6 bipolar cell marker Syt2 (red) and anti-GFP (green) were combined in the 
next staining. As seen in Figure 3.3.5 B, Syt2-IR was strong in the neurites of the cells 
and weak in their somata. However, somata (arrows) could be identified by carefully 
tracing the neurites. In this particular field of view, in addition to some neurons, very 
large and flat cells were observed in the GFP staining (Figure 3.3.5 A). Those large 
and flat cells are glia cells expressing GFP. Of the several GFP expressing neurons, 
two (arrows) were also found in the Syt2 staining. The marked area is shown at higher 
magnification in the lower images (Figure 3.3.5 D & E). It is clearly visible that the 
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processes (arrowheads) are immunoreactive for both antibodies. By counting the cells 
with Syt2-IR from several cultures, it was found that 98% (45/46) of Syt2-positive 
cells expressed GFP. The only Syt2-positive GFP-negative cell is shown in Figure 
3.3.6 (arrow). No GFP expression was observed in soma or neurites.  
 
 
Figure 3.3.6: A Syt2-immunoreactive cell that did not express GFP upon AAV2 
transduction. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for Syt2 in red. Arrow indicates a Syt2-positive cell that is negative for GFP.  
Scale bar = 20 µm. 
 
The transduction efficiency was also determined for amacrine cells. Antibodies 
against GlyT1 were chosen for glycinergic amacrine cells (Figure 3.3.7, A: GFP in 
green, B: GlyT1 in red). Six cells were labeled for GlyT1-IR. Five of them (arrows) 
were positive for GFP, while one cell (arrowhead) was negative. The overlay (Figure 
3.3.7 C) nicely presents five positive cells whose green somata are wrapped by a 
yellow ring. In total, about 80% (53/66 GlyT1-positive cells) expressed GFP. AAV2 is 
well suited to transduce glycinergic amacrine cells.  
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Figure 3.3.7: Identification of glycinergic amacrine cells among AAV2-GFP 
transduced cells. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for GlyT1 in red. Arrows indicate infected cells immunoreactive for GlyT1. Arrowhead indicates a 
GlyT1-positive cell that is negative for GFP. 
Scale bar = 20 µm.  
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GABAergic amacrine cells were labeled by antibodies against GAD67. 
GAD67-staining revealed four GABAergic cells in the image (Figure 3.3.8 B, red), 
which were immunoreactive in their cytosol and numerous neurites. Five neurons in 
the same field showed GFP-expression (Figure 3.3.8 A). Only two of them (arrows) 
were double labeled for GAD67, leading to a yellow appearance in the overlay 
(Figure 3.3.8 C). In total, 56 out of 72 GAD67-positive cells (nearly 80%), were 
transduced by AAV2.  
The last cell type that was tested for GFP expression was the NOS-positive amacrine 
cell. Two examples are presented in Figure 3.3.9, where GFP-IR is in green and 
NOS-IR is in red. In panel A, one NOS-immunoreactive cell (arrow) was found to 
express GFP. In panel B, another NOS-immunoreactive cell (arrowhead) found in the 
same culture was negative for GFP-IR. Roughly 50% (14/29) of the NOS-positive 
cells were GFP-positive.   
The transduction efficiency and specificity was determined for all AAV serotypes 
used in this study. Data are presented in Table 3.3.1. In this table, the first horizontal 
line lists the serotypes of AAVs, and the first vertical column lists the antibodies that 
were used for cell type identification. The transduction efficiency is given in total 
numbers and percentage values. 
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Figure 3.3.8: Identification of GABAergic amacrine cells in AAV2-GFP transduced 
cultures. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for GAD67 in red. Arrows indicate infected cells immunoreactive for GAD67.  
Scale bar = 20 µm.  
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Figure 3.3.9: Identification of NOS amacrine cells in AAV2-GFP transduced 
cultures. 
Dissociated retinal cultures transduced by AAV2-GFP were immunostained for GFP in green and 
for NOS in red. Arrow indicates an infected cell immunoreactive for NOS. Arrowhead indicates a 
NOS-positive cell that is negative for GFP. 
Scale bar = 20 µm. 
 
Generally speaking, AAV2 can be considered as the best choice for retinal 
transduction. It could infect all cell types of interest. The transduction rate reached 
around 100% for CaBP-immunoreactive cells and Syt2-immunoreactive cells, 
followed by about 80% for GlyT1- and GAD67-immunoreactive cells and nearly 50% 
for the NOS-immunoreactive cells. Although only 10% of the 
recoverin-immunoreactive cells were transduced by AAV2, this rate is the highest rate 
compared with the other serotypes. AAV6 was also able to infect all cell types of 
interest. However, the transduction efficiency was on average lower than for AAV2. 
While transduction efficiency was still above 90% for CaBP-immunoreactive and 
Syt2-immunoreactive cells, it considerably decreased for GlyT1-immunoreactive cells, 
GAD67-immunoreactive cells and NOS-immunoreactive cells. AAV1 infected 
horizontal cells well and showed some selectivity for glycinergic cells rather than 
GABAergic cells. AAV4 seemed to infect mainly recoverin-immunoreactive cells and 
few Syt2-immunoreactive cells. Both AAV8 and AAV9 did not target photoreceptors. 
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But AAV8 overall had a higher transduction efficiency than AAV9. Except for AAV2, 
the remaining serotypes all had zero or very low transduction efficiency for 
NOS-positive cells.  
Table 3.3.1: Transduction efficiency of AAV serotypes in dissociated retinal 
cultures. 
 AAV1 AAV2 AAV4 AAV6 AAV8 AAV9 
Recoverin 11/207 5% 16/156 10% 7/86 8% 8/121 6% 0/56 0% 0/135 0% 
CaBP 34/35 97% 55/55 100% 0/56 0% 48/50 96% 47/58 81% 25/55 45% 
Syt2 22/32 69% 45/46 98% 3/51 6% 59/63 94% 48/85 56% 31/65 48% 
GlyT1 24/78 30% 53/66 80% 0/77 0% 31/70 44% 11/63 17% 9/88 10% 
GAD67 0/72 0% 56/72 78% 0/65 0% 24/70 34% 25/70 36% 13/70 19% 
NOS 0/30 0%- 14/29 48% 0/36 0% 3/38 8% 0/39 0% 2/43 5% 
             
As a conclusion, AAV2 was able to not only infect many types of cells but also 
successfully transduce each cell type at a high rate. Thus, AAV2 was chosen to 
express Cygnet-2.1 in retinal neurons.  
3.3.2 AAV transduction in organotypic retinal whole-mount cultures 
Retinal whole-mount cultures are closer to the native tissue than dissociated cultures. 
Therefore, the transduction efficiency of AAVs was also characterized in 
whole-mount cultures. As the morphology of retinal cell types is well preserved in 
whole-mount cultures, the specificity of the transduction could be further verified. 
AAVs encoding GFP were applied immediately after explanting the whole-mounts 
onto the membrane. In the first set of experiments with the cultures being in wells 
with culturing medium, AAVs were added directly on top of the cultures. After 8 days 
in culture, no GFP expression was detectable (data not shown). In the second set of 
experiments, whole-mount cultures were covered with a drop of AAV solution and 
were incubated for 15 ~ 20 minutes in a sterile environment at 37°C and 100% 
humidity. After that, cultures were transferred to wells containing culturing medium. 
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This procedure strongly increased the transduction efficiency. After about 4 days in 
culture, first evidence for GFP expression was detected. On the 8th day of cultivation, 
whole-mounts were fixed and sectioned vertically for further immunocytochemical 
investigations.  
In general, the transduction efficiency in the whole-mount cultures was more 
heterogeneous than in dissociated cultures. Even within one whole-mount, GFP 
expression could be strong in one part, but much lower in other parts of the retina. 
Moreover, in stark contrast to the results obtained in dissociated retinal cultures, 
irrespective of the AAV serotype (AAV1, AAV2, AAV4, AAV6, AAV8, and AAV9) 
used, predominantly Müller cells were transduced. Figure 3.3.10 shows two examples 
of whole-mount cultures transduced by AAV2-GFP. Both in the folded culture (panel 
A) and flattened culture (panel B), cells expressing GFP were observed with the same 
morphology. Their somata (arrows) were always in the INL and only two thick 
processes protruded from the soma towards different directions: one (white 
arrowheads) towards the outer limiting membrane and another (yellow arrowheads) 
towards the inner limiting membrane. Often along these processes, some small spikes 
could be recognized. These cells own the very typical morphology of Müller cells. In 
the retina glutamine synthetase (GS) is exclusively expressed in Müller cells (Linser 
et al., 1984; Derouiche and Rauen, 1995). Counterstainings for GS-immunoreactivity 
(GS-IR, red) are shown in the overlay panels C & D. Most GFP-expressing cells 
appear in yellow due to co-staining with both antibodies. In the right-most cell in the 
folded culture (A) GS-IR is less clear. The antibody against GS exhibits low 
penetration. As the cell resides deep in the tissue, it is barely stained for GS. 
Nevertheless, according to its unique morphology, it can still be identified as Müller 
cell. Besides Müller cells, a very small number of photoreceptors and horizontal cells 
were also found that expressed GFP in both types of cultures (data not shown).  
106 
 
Results 
 
Figure 3.3.10: GFP expression in whole-mount retinal cultures upon AAV2-GFP 
transduction. 
Vertical sections of whole-mount retinal cultures transduced by AAV2-GFP were immunostained 
for GFP in green and for GS in red. A & C are from a folded culture, B & D from a flattened 
culture. The dotted lines divide the upper and lower parts of the folded culture. The orange bars 
represent the culturing membrane in the flattened culture. Arrows indicate the somata of 
AAV2-GFP transduced Müller cells. White arrowheads indicate the outward projections and 
yellow arrowheads indicate the inward projections.  
Scale bar = 20 µm.  
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Why is the transduction pattern of whole-mount cultures so different from that of 
dissociated cultures? In dissociated cultures, every cell is exposed to the medium and, 
thus, is accessible to the AAVs. In whole-mount cultures, most cells of interest are 
embedded within the tissue resulting in low accessibility. Müller cells extend their 
processes to the borders of the retina where they form large endfeet. Therefore, in 
both flattened and folded cultures Müller cells provide an accessible target for AAVs. 
This may explain why predominantly Müller cells were transduced in whole-mount 
cultures. However, the number of transduced Müller cells seemed higher in flattened 
cultures than in folded cultures.   
Conclusion for AAV-mediated transduction in vitro 
AAVs were found suitable to deliver foreign genes into retinal cells in vitro. Different 
AAV serotypes showed different specificity in the transduction of cell types in 
dissociated retinal cultures. AAV2 was able to infect many types of cells with high 
transduction efficiency. In whole-mount cultures the AAV serotypes tested (AAV1, 
AAV2, AAV4, AAV6, AAV8, and AAV9) did not show the same specificity as in 
dissociated retinal cultures but transduced predominantly Müller cells.  
 
3.4 AAV-mediated transduction in vivo  
3.4.1 Expression of GFP in the retina using AAV-mediated transduction in vivo 
This section describes the results obtained when AAVs encoding GFP were delivered 
via ocular injection to infect retinal cells in vivo. Injections were performed on mice 
of the postnatal stage P5. Only one eye of each mouse was injected. The other eye 
served as control. After the eye had been exposed, a small opening was made and a 
thin needle was inserted into the eye. Once the needle reached the bottom of the eye 
ball, it was pulled back a little bit. A precise volume of 0.5 μl virus suspension was 
injected. As there is no clear vision through the optics of the eye at this developmental 
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stage, it could not be determined whether the injection was subretinal or intravitreal. 
But in this manner the viruses were injected as closest to the retina as possible. After 5 
weeks or longer, injected mice were sacrificed and their retinae were isolated for 
immunohistochemical analysis. In this part, a total of 23 retinae were studied: 5 for 
AAV1-GFP, 4 for AAV2-GFP, 3 for AAV4-GFP, 3 for AAV6-GFP, 4 for AAV8-GFP, 
and 4 for AAV9-GFP.  
Figure 3.4.1 displays an overview of the transduction efficiency of the different AAV 
serotypes in vivo. All microphotographs in this figure were captured by detecting the 
endogenous fluorescence of GFP. In general, all tested AAV serotypes were able to 
transduce retinal cells in vivo. Again, AAV2-GFP showed the highest transduction 
efficiency. However, in all transduced retinae at several sites discrete disturbances of 
the retinal layering were observed. These disturbed structures might be due to 
mechanical damage during the injection and occured independent of the AAV 
serotype used. Moreover, higher GFP expression was mostly found in such disturbed 
regions. Probably, the mechanical damage made these regions more accessible to the 
viruses. Nevertheless, in retinae transduced by AAV2-GFP, AAV8-GFP, and 
AAV9-GFP, GFP expression was also observed within well-preserved regions. In the 
following, the transduction pattern of each AAV serotype will be discussed in detail.   
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Figure 3.4.1: GFP expression in the retina upon AAV transduction in vivo. 
Retinae were transduced in vivo by AAV1-GFP (A & B), AAV2-GFP (C & D), AAV4-GFP (E & F), 
AAV6-GFP (G & H), AAV8-GFP (I & J), and AAV9-GFP (K & L). Whole-mounted retinae are 
shown in A, C, E, G, I & K. Vertical sections are shown in B, D, F, H, J & L. 
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The green fluorescence represents endogenous GFP fluorescence. A, dotted line marks the region 
of high transduction efficiency; arrowhead indicates the injection site; arrows indicate sites of 
strong GFP expression. In B, dotted lines indicate retinal layering; arrowheads mark infected 
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photoreceptors; arrows indicate infected Müller cell processes. In C, arrows indicate strong 
GFP-expression. In D, arrowheads indicate infected amacrine cells in the INL; big arrows 
indicate infected neurons in the GCL; small arrows indicate infected Müller cell endfeet. In F, the 
dotted lines mark the retinal layering. In H, the dotted lines mark the retinal layering; arrows 
indicate infected cells, presumably RPE cells. In K, the dotted line marks the region of GFP 
expression; arrow indicates the injection hole. In L, big arrowheads indicate processes of infected 
Müller cells; big arrows indicate infected bipolar cells in the INL; small arrows indicate infected 
amacrine cells in the INL; small arrowheads indicate infected neurons in the GCL.  
Scale bar = 1 mm in A, C, E, G, I & K.  
Scale bar = 20 μm B, D, F, H, J & L. 
 
AAV1-GFP transduction is shown in a retinal whole-mount preparation in Figure 
3.4.1 A. Strong green fluorescence was observed at several discrete areas (arrows). A 
hole in the retina is marked by the arrowhead. It might be the result from the needle 
damaging the retina during the injection. Around the hole (marked by the dotted line), 
the number of GFP-positive cells was higher than in other regions, probably due to 
the short diffusion distance for viral particles from the injection site. Vertical sections 
of retinae transduced by AAV1-GFP, however, revealed that in regions with high GFP 
expression the retinal layering was strongly disturbed. An example is shown in B. The 
retina was folded and it was difficult to identify layers unequivocally. Most labeled 
cells display thick processes with small spikes (arrows), typical for Müller cells. Few 
infected small cells were found in the outer retina (arrowheads) - probably 
photoreceptors. In well-preserved regions, no GFP expression was observed or, 
occasionally, few photoreceptors displayed green fluorescence (data not shown).  
Figure 3.4.1 C & D show retinae that were transduced by AAV2-GFP. GFP expression 
was high almost throughout the entire retina (C). At several sites (arrows) GFP 
expression level was particularly high. Similar to data shown in B, in these regions the 
retinal structure was damaged (data not shown). In the remaining parts of the tissue 
not only the retinal structure was better preserved, but also a decent number of cells 
expressing GFP was observed. The vertical section in D was obtained from a better 
preserved part of an AAV2-GFP infected retina. The retinal layering was intact. 
However, the thickness of the ONL was reduced compared to a normal retina, 
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indicating that a pronounced number of photoreceptors had degenerated. The inner 
retina did not exhibit signs of degeneration. In all layers, many cells were found to 
express GFP. Besides many photoreceptors in the ONL and several neurons (big 
arrows) in the GCL, also a substantial number of GFP-positive cells were found in the 
INL. The cells close to the IPL were easily identified as amacrine cells (arrowheads). 
The remaining positive cells in the INL were more difficult to identify. Big end feet in 
the GCL (small arrows) indicated that Müller cells had been infected. The question 
whether bipolar cells were transduced will be analyzed using counterstainings in the 
next chapter.  
For AAV4-GFP the overall expression level of GFP was low (Figure 3.4.1 E). When 
analyzing vertical sections of AAV4-GFP transduced retinae, all cells expressing GFP 
were located in the outer part of the retina and were identified as photoreceptors due 
to their small somata. GFP expression was mostly observed in disordered regions. In 
the example shown in F, the entire outer part of the retina and the INL were folded 
like a wave. Although the IPL and the GCL were preserved, there was no GFP 
expression at all in the inner retina.  
Figure 3.4.1 G shows a whole-mounted retina infected by AAV6-GFP. In dissociated 
retinal cultures, the transduction efficiency of AAV6-GFP was rather high. In contrast, 
in vivo the transduction efficiency was found extremely low in all injections. Spot-like 
weak green fluorescence was observed. When looking at the vertical section shown in 
H, the cells expressing GFP were located at the outer limiting border of the retina. 
Sometimes, GFP-positive cells (arrows) were embedded in the trough of the 
wave-like structures formed by the folded outer layers. Their large somata and the fact 
that no processes were observed could suggest that they were cells of the retinal 
pigment epithelium (RPE) sticking to the tissue when the retina was isolated from the 
eye cup. Unfortunately, within the proper retina no sign of GFP expression was 
detected.  
In Figure 3.4.1 I, a number of cells were observed to express GFP in the 
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whole-mounted retina transduced by AAV8-GFP. However, the density of 
GFP-positive cells was lower than in retinae transduced by AAV1 and AAV2; and 
there was no region with particularly higher transduction efficiency. Photoreceptors 
were the main targets for AAV8. As is shown in Figure 3.4.1 J, in a well-preserved 
region GFP expression was found in photoreceptors in the ONL, similar to the 
AAV4-GFP transduced retina. In disturbed regions, nevertheless, very rarely Müller 
cells, amacrine cells, displaced amacrine cells and ganglion cells were also found to 
express GFP (data not shown).  
AAV9 also showed high transduction efficiency in the mouse retina in vivo. The 
typical infection pattern is presented in one whole-mount (Figure 3.4.1 K). A great 
number of cells were found with strong GFP expression in a large area of the retina 
(marked by the dotted line). An arrow indicates a hole where the viruses were injected. 
The GFP expression was high near the hole and gradually dropped towards the 
periphery. When studying vertical sections of AAV9-GFP transduced retinae, very 
strong GFP expression was mostly found in damaged parts of each retina (data not 
shown), like in Figure 3.4.1 B & F. However, the well preserved parts also showed a 
good transduction pattern. One vertical section is shown in Figure 3.4.1 L. In the ONL, 
a very limited number of photoreceptors were infected. Some bipolar cells (big arrows) 
and amacrine cells (small arrows) in the INL and some displaced amacrine cells 
(small arrowheads) in the GCL were found to express GFP. Besides, Müller cells also 
expressed GFP. Their typical thick processes are indicated by big arrowheads.  
Comparing the transduction efficiency of the different AAV serotypes in vivo, AAV2 
was again the most promising serotype due to its high efficiency. In particular, many 
cells in the INL were targeted by AAV2. In the following part, AAV2-GFP infected 
neurons in the INL will be further analyzed to find out if they are also involved in the 
NO-cGMP pathway.  
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3.4.2 AAV2 targeted neurons in the INL involved in NO-cGMP pathway.  
The key enzyme involved in the NO-cGMP pathway is the soluble guanylate cyclase 
(sGC). Expression of Cygnet-2.1 in these cells is of particular interest to study the 
NO-stimulated synthesis of cGMP. Ding and Weinberg studied the distribution of sGC 
in rat retina using a polyclonal antibody raised against the β1 subunit of sGC (Ding 
and Weinberg, 2007). Here, I employed this antibody to determine whether 
sGC-immunoreactive cells were targeted by AAV2.  
Figure 3.4.2 shows a vertical section of an AAV2-GFP transduced mouse retina that 
was labelled for sGC in red. The green signal represents endogenous GFP 
fluorescence. The inner retina is shown at higher magnification in B, D, and F. In A, 
many cells in the ONL and a few cells in the INL were observed with good GFP 
expression. In the sGC-staining (C & D), also many cells in the INL were found 
immunoreactive. In the overlay (E & F), two sGC-positive cells (arrows) also showed 
green fluorescence. They were identified as bipolar cells due to the position and shape 
of their somata and their dendrites directed towards the OPL. Their axon terminal 
systems could not be resolved. Another green bipolar cell (arrowhead) with clear axon 
was negative for sGC-IR. Its axon ended in the innermost layer of the IPL, suggesting 
that this cell was a rod bipolar cell.  
PKCα-staining was performed on other sections from the same retina to identify rod 
bipolar cells. Quite a number of rod bipolar cells were found to be infected by AAV2. 
One example is shown in Figure 3.4.3. Four GFP-expressing cells (arrowheads) 
appeared immunoreactive for PKCα. Another cell with GFP fluorescence (arrow in A) 
was negative for PKCα. Based on the form of the soma and a weak endfoot staining in 
the GCL, this cell is most likely a Müller cell. By analyzing sections from retinae 
transduced in vivo by AAV2 (N = 4), rod bipolar cells and Müller cells represented a 
large fraction of GFP-expressing cells in the INL.  
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Figure 3.4.2: sGC-immunoreactive bipolar cells targeted by AAV2. 
A vertical section of AAV2-GFP transduced retina was immunostained for sGC in red. Green label 
reflects endogenous GFP fluorescence. Higher magnification of the inner retina is shown in B, D 
& F. Arrows indicate two cells positive for GFP and sGC-IR. Arrowhead indicates a rod bipolar 
cell expressing GFP only.  
Scale bar = 20 μm. 
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Figure 3.4.3: Rod bipolar cells infected by AAV2. 
A vertical section of AAV2-GFP transduced retina was immunostained for PKCα in red. Green 
label represents endogenous GFP fluorescence. Arrowheads indicate several PKCα-positive rod 
bipolar cells expressing GFP. Arrow indicates one GFP-expressing Müller cell. 
Scale bar = 20 μm. 
 
It was not possible to systematically count and statistically classify all cell types in the 
inner retina that were infected by AAV2. Nevertheless, by using counterstainings with 
cell-type specific markers, I also found type 3a and type 5 bipolar cells that were 
infected by AAV2-GFP (data not shown). These two types of bipolar cells displayed 
cGMP-like IR upon stimulation with NO donors (Zhao, 2010).  
Besides bipolar cells, sGC-immunoreactive amacrine cells were also found to become 
transduced by AAV2-GFP. Figure 3.4.4 A shows one sGC-positive amacrine cell 
(arrow) in the INL with GFP expression. In panel B, two displaced amacrine cells 
(arrows) in the GCL were found positive for both sGC and GFP.     
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Figure 3.4.4: sGC-immunoreactive amacrine cells targeted by AAV2.  
A vertical section of AAV2-GFP transduced retina was immunostained for GFP in green and sGC 
in red. Arrows indicate sGC-positive amacrine cells in A and sGC-positive displaced amacrine 
cells in B, which were infected by AAV2. 
Scale bar = 20 μm. 
 
Conclusion for AAV-mediated transduction in vivo 
From all serotypes, AAV2-GFP displayed the highest transduction efficiency in vivo 
and targeted sGC-immunoreactive cells. Therefore, AAV2 was chosen as the vector to 
introduce the Cygnet-2.1 sensor into retinal neurons to investigate the NO-induced 
cGMP synthesis.   
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3.5 AAV2-mediated expression of Cygnet-2.1 in dissociated retinal cultures  
3.5.1 Expression of the viral form of Cygnet-2.1 sensor 
In order to produce AAVs encoding Cygnet-2.1, the original cDNA had to be 
modified and cloned into a viral vector. Prior to using this vector to generate viruses, 
the functionality of this Cygnet-2.1 variant expressed from the viral plasmid, termed 
vCygnet-2.1, had to be tested.  
For this purpose, FlpTS GC-A cells were co-transfected with cDNAs encoding 
vCygnet-2.1 and PDE5a. Figure 3.5.1 A shows a screenshot from one of the imaging 
experiments, two transfected cells were recorded. Cygnet-2.1 sensors expressed from 
the viral plasmid were distributed in the cytosol, the same distribution pattern 
observed upon the expression from the original cDNA (Figure 3.1.3).  
The functionality of the sensor was proven in the imaging experiments. In Figure 
3.5.1 B, the signals of Cygnet-2.1 recorded from the two cells in Figure 3.5.1 A were 
plotted as the change in the ratio CFP/YFP (ΔR/R0) over time. Upon each of the three 
stimulations with ANP, a transient change was observed indicating a change in FRET 
efficiency. The maximum FRET change (14% ~ 19%) was similar to that recorded in 
previous experiments using the original cDNA (Chapter 3.1). As a conclusion, the 
sensors expressed from the modified DNA vCygnet-2.1 were fully functional.   
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Figure 3.5.1: Functional sensors can be expressed from vCygnet-2.1 plasmid upon 
transfection.  
A: Screenshot from an imaging experiment recording two FlpTS GC-A cells expressing sensors 
from the vCygnet-2.1 plasmid.  
B: The FRET change of both cells was plotted over time. ANP (1nM) was applied during seconds 
30 to 60, 150 to 210, and 300 to 330, respectively. In each case, both cells showed rapid FRET 
changes after both onset and offset of ANP, indicating transient elevation of the intracellular 
cGMP concentration upon application of ANP.  
Scale bar = 20 μm.  
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3.5.2 cGMP-imaging of dissociated retinal cultures using Cygnet-2.1 
Before I used Cygnet-2.1 in the dissociated retinal cell culture, I tested whether the 
synthesis of cGMP in retinal neurons could be stimulated by incubation with NO 
donors. An antibody against cGMP was used to detect cGMP-IR (Zhao, 2010). 
Cultures were incubated either with the NO donors SNP (1 mM) or SNAP (100 μM) 
in Ames’ medium or with Ames’ mdium alone for 10 minutes and fixed immediately. 
After fixation, cultures were immunostained for cGMP and sGC. Nuclei were stained 
with TO-PRO3. The immunocytochemical results are shown in Figure 3.5.2. The cells 
(arrows and arrowheads) that were immunoreactive for sGC comprised about 15% of 
the total population of cultured cells. After incubation with the NO donors SNP (A-C) 
and SNAP (D-F), cGMP-IR was found in nearly all sGC-positive cells (marked by 
arrows). Only few sGC-positive cells (arrowheads) were negative for cGMP-IR. 
Hence, cGMP-IR and sGC-IR matched very well. When cultures were incubated 
without NO donor (G-I), sGC-positive cells (arrowheads) showed no cGMP-IR. 
However, some small cells that were negative for sGC displayed cGMP-IR. Based on 
the soma size and appearance, these cells resembled photoreceptors. Photoreceptors 
express membrane bound pGCs that cannot be activated by NO. Double-stainings for 
cGMP and recoverin did not yield a perfect match between cGMP-IR and 
recoverin-IR (data not shown).  
In summary, the immunocytochemical approach proved that the intracellular cGMP 
concentration in cultured sGC-positive retinal cells can be greatly increased upon NO 
stimulation.  
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Figure 3.5.2: Stimulation with NO increased cGMP-IR in sGC-positive cells in 
dissociated retinal cultures.  
A-C, Cultures incubated with 1 mM SNP; D-F, cultures incubated with 100 μM SNAP; G-I, 
cultures incubated with Ames’ mdium. All arrows indicate sGC-positive cells with cGMP-IR. All 
arrowheads indicate sGC-positive cells without cGMP-IR.  
Scale bar = 20 μm. 
 
In the following experiments, dissociated retinal cultures were transfected with 
vCygnet-2.1 using lipofectamine on the 2nd day of cultivation. After 24 hours of 
expression, cells were used for cGMP-imaging. Unfortunately, the transfection 
efficiency was extremely low. Only 2 to 5 cells per coverslip were found to express 
Cygnet-2.1. By imaging many cultures (N>20), I found some cells (n=16) that 
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expressed the Cygnet-2.1 sensors and responded to the stimulation with exogenous 
NO.  
Figure 3.5.3 A displays a recording from one cell. A transient FRET change was 
recorded during the initial application of 100 μM SNAP. The CFP/YFP ratio increased 
fast by about 18% upon the onset of stimulation and decreased slowly upon washout. 
During the second stimulation, the NO donor and the PDE inhibitor IBMX were 
applied together for 1 minute. A similar fast increase in the ratio was recorded. The 
maximal FRET change was approximately 18%, similar to the previous peak. The 
FRET change could not be further increased by IBMX, suggesting that either 
stimulation with 100 μM SNAP already induced the maximal cGMP elevation in the 
cell or that the elevated cGMP concentration saturated the sensor. After the offset of 
the NO donor, IBMX was superfused continuously for another 1 minute. During this 
time, the signal barely decreased, indicating that degradation of cGMP was prevented 
by IBMX. Upon washout, the signal slowly recovered to baseline, which implicated 
the clearance of cGMP. The imaging results for the first time revealed the real-time 
dynamics of cGMP in retinal neurons. 
After the imaging, the coverslip was fixed and stained immunocytochemically. The 
double-staining (Figure 3.5.3 B-D) showed that the imaged cell was immunoreactive 
for sGC.  
NO is a radical and changes of the sensor signal observed in the presence of NO 
might be due to unspecific changes in the sensor properties induced by direct 
interaction of the sensor with NO. To rule this out, control experiments were 
performed in HEK-293 cells that have no sGC. Changes in the sensor signal in the 
presence of an NO donor would argue for unspecific effects of NO on the sensor 
protein. To this end, HEK-293 cells were transfected with the same DNA used in 
dissociated retinal cultures. Upon the expression of Cygnet-2.1, cells were imaged and 
stimulated with the same concentration of NO donor as in the retinal experiment. No 
FRET change was observed during stimulation (data not shown). These controls 
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indicate that the Cygnet-2.1 signals recorded in the retinal neuron shown in Figure 
3.5.3 were not due to an unspecific interaction of Cygnet-2.1 with NO but represented 
an increase in the internal cGMP concentration upon stimulation of sGC by NO.   
 
Figure 3.5.3: Real-time dynamics of intracellular cGMP monitored by transfected 
Cygnet-2.1 sensor in dissociated retinal culture.  
A: The FRET change of a cultured retinal neuron transiently transfected with Cygnet-2.1 was 
plotted over time. The NO donor SNAP (100 μM) was applied twice from 60 to 120 seconds and 
from 240 to 300 seconds, respectively. The PDE inhibitor IBMX (100 μM) was applied during 
seconds 240 to 360. The cell showed two fast FRET changes during the application of NO and 
slow recovery upon wash out. During the second application, the amplitude of the signal was not 
further increased by the co-perfusion of IBMX, but the duration was prolonged by further IBMX 
application. The right image shows a screenshot of the YFP channel of the imaged cell.  
B-D: The imaged cell in A was immunoreactive for sGC (red). 
Scale bar = 20 μm. 
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3.5.3 Transduction with AAV2-Cygnet-2.1 leads to non-functional sensor 
In the next set of experiments, AAV2 was used to express Cygnet-2.1 
(AAV2-Cygnet-2.1) in retinal dissociated cultures. Following the protocol used for 
AAVs-GFP transduction, retinal dissociated cultures were incubated with 
AAV2-Cygnet-2.1 on the 2nd day of cultivation. After six days of expression, cultures 
were used for cGMP-imaging. All imaging conditions were identical to those used in 
previous imaging experiments (like Figure 3.5.3 in Chapter 3.5.2). Fluorescence of 
the sensor proteins could be detected. However, the fluorescence intensity was lower 
than in cells transfected with lipofectamine, while the number of transduced cells per 
coverslip (> 100 cells/coverslip) was higher that the number of transfected cells (2 ~ 5 
cells/coverslip). A total of 76 recordings were performed on 25 independent cultures 
using the NO donor, SNAP. In none of the recorded cells a FRET change was 
observed upon stimulation with SNAP. Figure 3.5.4 A shows a recording of a 
AAV2-Cygnet-2.1 transduced cell. The signal was constant during the whole 
recording, irrespective of the stimulation with SNAP (100 μM). Another 6 recordings 
from 4 individual samples were performed with a different NO donor, SNP. Again, no 
responses to SNP were observed. Figure 3.5.4 B shows a recording with prolonged 
application of SNP (1 mM).  
There are two possible explanations for the negative results: 1) AAV2-Cygnet-2.1 
transduced cells in dissociated cultures did not contain sGC and, therefore, did not 
respond to NO; or 2) the sensors expressed upon transduction with AAV2-Cygnet-2.1 
were not functional.    
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Figure 3.5.4: Cygnet-2.1 sensors seem non-functional in dissociated retinal 
cultures upon AAV2-Cygnet-2.1 transduction. 
A: The sensor signal of a cultured retinal cell transduced with AAV2-Cygnet-2.1 was plotted over 
time. No signal change was recorded upon the stimulation with SNAP (100 μM).  
B: The sensor signal of a cultured retinal cell transduced with AAV2-Cygnet-2.1 was plotted over 
time. No signal change was recorded upon the stimulation with SNP (1 mM).  
Images in A and B show screenshots of the YFP channel for each cell.  
Scale bar = 20 μm. 
 
The first possibility could be tested by immunohistochemical detection of sGC in 
transduced neurons. Unfortunately, the number of cells showing fluorescence upon 
transduction with AAV2-Cygnet-2.1 was much higher than the number of fluorescent 
cells upon lipofectamine transfection. In addition, the fluorescence intensity in 
AAV2-Cygnet-2.1 transduced cells was much lower than that in the cells transfected 
with lipofectamine. Therefore, it was extremely difficult to identify the cells that had 
been imaged again after the immunocytochemistry. However, there are several clues 
supporting the assumption that the sensor is non-functional. First, in all cells that 
expressed functional Cygent-2.1, sensor fluorescence was restricted to the cytoplasm 
while the nucleus was always devoid of fluorescence (see e.g. Figure 3.5.3 A 
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screenshot and B-D). The same is true for other sensor proteins of similar composition, 
e.g. the cAMP sensor Epac (data not shown). Most likely, the full sensor protein is too 
large to pass the nuclear pores. In cells that had been transduced with 
AAV2-Cygnet-2.1, fluorescence was also detected in the nucleus. This may indicate 
that the sensor protein is not intact and that the smaller fluorescent fragments can 
enter the nucleus. In this case, it is important to study not only the ratio change (ΔR), 
but also the initial ratio of CFP/YFP (R0). The average R0 of cells expressing 
Cygnet-2.1 upon AAV2-Cygnet-2.1 transduction (n=25) was nearly 2 times higher 
than the average R0 of cells transfected with Cygnet-2.1 using lipofectamine (n=31) 
(Figure 3.5.5). This unexpected high R0 of AAV2-Cygnet-2.1 may indicate that CFP 
and YFP exist independent of each other in the cell because the sensor is degraded.  
 
Figure 3.5.5: Baseline ratio of Cygnet-2.1 upon AAV2-Cygnet-2.1 transduction was 
higher than the ratio upon lipofectamine transfection. 
Baseline ratio of Cygnet-2.1 sensors upon lipofectamine transfection was averaged from 31 
individual recordings (left bar), while baseline ratio of the sensors after AAV2-Cygnet-2.1 
transduction was averaged from 25 individual recordings (right bar). The R0 after viral 
transduction was nearly two times higher than after lipofectamine transfection. P=3.16×10-10 by 
t-test.   
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Additional controls were performed in FlpTS GC-A cells, the cell line that had been 
used to characterize Cygnet-2.1 in initial experiments (compare Chapter 3.1). Cells 
were transduced with AAV2-Cygnet-2.1. After four days, fluorescence was observed 
in many cells and cells were used for imaging experiments. Within 4 individual 
recordings including 20 different cells, no FRET change was observed upon ANP 
stimulation. One of the recordings is shown in Figure 3.5.6. Five FlpTS GC-A cells 
were recorded in the field of view (screenshot). Between seconds 60 to 120, ANP (1 
nM) was applied but no change in the fluorescent signal was recorded. Once again, 
fluorescence was found in both nucleus and cytosol quite different from the situation 
in lipofectamine transfected FlpTS GC-A cells (see Figure 3.1.2 and Figure 3.5.1 A), 
but similar to virally transduced dissociated retinal cultures (Figure 3.5.4 screenshots).  
 
Figure 3.5.6: AAV2-Cygnet-2.1 transduction did not yield functional Cygnet-2.1 
sensor in FlpTS GC-A cells.  
The sensor signal of five FlpTS GC-A cells transduced with AAV2-Cygnet-2.1 was plotted over 
time. No signal change was recorded upon the application of ANP (1 nM) between 60 to 120 
seconds.  
Right image shows a screenshot of the YFP channel for these five cells. 
Scale bar = 20 μm. 
 
Conclusion for AAV-mediated expression of Cygnet-2.1 
All results in this chapter strongly suggest that Cygnet-2.1 sensors expressed upon 
AAV-mediated transduction were not functional in the target cells.  
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The intracellular messenger cGMP is supposed to play a vital role in retinal signal 
processing and adaptation. The aim of the present study was to establish a method that 
allows to spatially and temporally monitor changes in the internal cGMP 
concentration in retinal cells using the genetically encoded sensor Cygnet-2.1. As a 
first step, the sensor had to be characterized using a cell model in which cGMP 
synthesis could be reliably and reproducibly triggered. I chose the FlpTS GC-A cell 
line. The cell line expresses the particulate guanylate cyclase A (pGC-A) which can be 
activated by the atrial natriuretic peptide ANP. Cygnet-2.1 reliably revealed the 
synthesis and degradation of intracellular cGMP upon stimulation with ANP (Chapter 
3.1). As the next step, Cygnet-2.1 had to be expressed in retinal cells. To this end, 
retinal cultures were established (Chapter 3.2) and seven different AAV serotypes 
encoding GFP were screened for their transduction efficiency in this in vitro model. 
AAV2 was selected as the most promising vector based on its wide range of 
transduction patterns among the retinal cell types and the high transduction efficiency 
(Chapter 3.3). AAV-mediated transduction was also established in vivo. AAVs were 
delivered via ocular injection to newborn mice (Chapter 3.4). Again, AAV2 was 
determined as the most promising candidate for transduction of retinal neurons. 
Finally, Cygnet-2.1 sensors were expressed in dissociated retinal cultures by using 
lipofectamine transfection and AAV-mediated transduction. Using lipofectamine 
transfection, changes in Cygnet-2.1 fluorescence revealed a fast increase in the 
internal cGMP concentration upon NO stimulation in cultured retinal neurons that 
were immunoreactive for sGC. Upon AAV2-mediated transduction, no change in the 
Cygnet-2.1 fluorescence could be detected in retinal cells upon stimulation with NO 
donors or in the FlpTS GC-A cells upon stimulation with ANP. Most likely, 
AAV-mediated transduction did not yield functional Cygnet-2.1 sensors (Chapter 3.5). 
Nevertheless, the proof of principle experiments clearly demonstrated that it is 
possible to investigate cGMP metabolism in the retina under physiological conditions 
using Cygnet-2.1. Once functional Cygnet-2.1 can be expressed upon viral 
129 
 
References 
transduction, this project can be carried on. In the following, I will discuss each of the 
above mentioned steps in an own chapter. 
 
4.1 Sensitivity and selectivity of Cygnet-2.1 
As a first step, Cygnet-2.1 had to be characterized using the FlpTS GC-A cell model 
in which cGMP synthesis could be triggered by ANP. Cygnet-2.1 reliably revealed the 
synthesis and degradation of intracellular cGMP upon stimulation with ANP (Chapter 
3.1). Cygnet is the first genetically encoded FRET-based cGMP sensor (Honda et al., 
2001). Honda and coworkers used N-or C-terminally truncated versions of the type I 
α isoform of protein kinase G (PKG-Iα) and fused it to the two fluorescent proteins 
CFP and YFP that can work as a FRET pair. One N-terminally truncated sensor 
version showed a decreased FRET efficiency upon cGMP binding and was called 
Cygnet-1 (cyclic GMP indicator using energy transfer). However, this first sensor still 
displayed kinase activity. To silence the kinase activity, a catalytically inactive mutant 
Cygnet-2 was generated, but, with relatively low sensitivity (KD (cGMP) = 1.9 µM). 
Native PKG-Iα has a KD for cGMP of approximately 100 nM (Ruth et al., 1991). In 
the advanced version Cygnet-2.1, YFP was substituted by a pH-insensitive YFP 
version and its sensitivity was greatly improved with an apparent KD (cGMP) of 600 
nM (Honda et al., 2005). The dynamic working range of Cygnet-2.1 was described to 
be from 11 nM to 15 µM with a maximal FRET change of 48%. All these data were 
obtained from titration experiments performed in cuvettes (Honda et al., 2001; Honda 
et al., 2005). Until now, a reliable quantification of Cygnet-2.1 has not been 
performed in living cells. The intracellular environment of living cells comprises 
many influences like pH, temperature, protein-protein interaction etc. which might 
affect the performance of the sensor. Therefore, in my thesis, the percentage of FRET 
change could not be correlated quantitatively to the internal cGMP concentration. 
Instead, changes in the CFP/YFP ratio (or the FRET changes) were only evaluated in 
a qualitative way: 1) if the ratio increased, it was assumed that the intracellular cGMP 
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concentration increased; 2) if the ratio decreased, it was assumed that the intracellular 
cGMP decreased; 3) if the ratio remained constant, it was concluded that the 
intracellular cGMP concentration did not change.  
In FlpTS GC-A cells that served as model system, the maximum FRET change was in 
the range of 12% ~ 25% (Chapter 3.1). This is similar to results reported from 
cultured vascular smooth muscle cells (Honda et al., 2005). In these cells the brain 
natriuretic peptide (BNP) produced a 20% FRET change in Cygnet-2.1 upon 
stimulation of the pGC-A. Based on their calibration, the FRET change might indicate 
an increase of the intracellular cGMP concentration in FlpTS GC-A cells to 200 ~ 800 
nM. When the FlpTS GC-A cells were transfected with the cGMP specific 
phosphodiesterase PDE5a, the maximum FRET change was reduced to 7% ~ 20% 
which might correspond to an increase of the cGMP concentration to 100 ~ 500 nM. 
As nearly all ratio curves showed plateau phases during stimulation, the lowered 
FRET change might indicate that PDE5a can efficiently lower the maximal cGMP 
concentration to about 50% ~ 60% of its value in the absence of PDE5a.  
Ideally, a cGMP sensor would only react to cGMP. In cuvette experiments Cygnet-2.1 
also responded to cAMP with a KD (cAMP) of 300 µM. Hence, Cygnet-2.1 displays a 
500 fold lower sensitivity for cAMP than for cGMP (Honda et al., 2005). Surprisingly, 
in my experiments Cygnet-2.1 yielded clear signals upon stimulation of FlpTS GC-A 
cells with noradrenaline that activates adrenergic receptors coupled to adenylate 
cyclase and cAMP synthesis (Figure 3.1.9, Chapter 3.1.4). As there is no evidence in 
the literature indicating that noradrenaline activates pGC, the most likely 
interpretation is that Cygnet-2.1 detected the rise in internal cAMP. As the signal was 
similar in amplitude to the signal induced by pGC-A activation, one would have to 
conclude that the internal cAMP concentration upon noradrenaline stimulation was 
roughly 500 fold higher than the cGMP concentration upon ANP stimulation. On the 
other side, the FRET-based sensor Epac1 has been generated for the detection of 
cAMP (Nikolaev et al., 2004). It seems that Epac1 can also react to cGMP. Epac1 has 
been reported to reveal changes in internal cGMP in Drosophila motoneurons 
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(Shakiryanova and Levitan, 2008). I also expressed Epac1 in FlpTS GC-A cells and 
recorded responses to stimulation with ANP (data not shown). Hence, both sensors do 
not only respond to changes in the concentration of their target cyclic nucleotide but 
also to changes of the “wrong” cyclic nucleotide. Therefore, the sensors should be 
used with the appropriate caution. For example in retinal cells, Cygnet-2.1 signals 
cannot always be unequivocally identified as changes in the internal cGMP 
concentration, especially if there is no clear relation to a stimulus. On the other hand, 
data are more easily to interpret if Cygnet-2.1 is used to monitor cGMP synthesis 
upon stimulation with NO donors acting on soluble guanylate cyclases. In this case, 
the most likely explanation for a Cygnet-2.1 signal is the increase in the internal 
cGMP concentration. Thus, in principle with the appropriate caution, Cygnet-2.1 
should be useful to study the NO-cGMP pathway in the retina.  
 
4.2 Development, degeneration and remodelling of retinal culture 
In order to develop techniques to express Cygnet-2.1 in retinal cells, three types of 
retinal cultures were established as model systems. To express Cygnet-2.1, two 
different techniques were used: transfection using the lipofectamine method and 
transduction using AAVs. AAV-mediated transduction was studied using seven 
different serotypes of AAVs encoding GFP. During the thesis I focused on organotypic 
retinal whole-mount cultures and dissociated retinal cell cultures. In retinal 
whole-mount cultures, the intact retina could be cultured up to 16 days, while mostly 
maintaining the typical organization. Clear retinal layering could be observed 
throughout the culture. In dissociated retinal cell cultures, all main types of retinal 
neurons could be grown on coated coverslips and survived for more than 4 weeks. 
However, degeneration also occurred in all retinal cultures and limited the time frame 
of cultivation.  
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4.2.1 Organotypic retinal whole-mount culture 
In this study, retinae of young mice at P8 were cultured in two ways: either “folded” 
or “flattened”. In both cases, the retinal layering could be preserved for 16 days. In 
addition, because at P8 the retina is not fully mature; the retinal explants still can 
develop during cultivation. As is shown in the recoverin-staining (Figure 3.2.1, 
Chapter 3.2), in vivo type 2 bipolar cells became recoverin-immunoreactive at P10. In 
both folded and flattened cultures of P8 retina, type 2 bipolar cells turned 
immunoreactive for recoverin after four days of cultivation. Hence, compared to the 
native tissue, the recoverin expression was delayed for two days, yet type 2 bipolar 
cells were still capable of developing in vitro. Nevertheless, cultivation certainly has 
effects on the tissues. Not only recoverin-IR in type 2 bipolar cells was delayed, but 
PKCα-IR in rod bipolar cells was delayed (Figure 3.2.2) as well. Whether this 
indicates lack of certain factors needed for development or time needed to recover 
from the isolation procedure cannot be decided.  
However, in both types of whole-mount cultures, degeneration was always observed 
and was most pronounced in that part of the retina that had attached to the membrane.  
In folded cultures, two layers of the retinal tissue were sandwiched and placed onto 
the membrane. As is shown in cell type specific immunostainings (Figure 3.2.1 - 3.2.4, 
Chapter 3.2), the lower part of the tissue that was attached to the membrane showed 
very fast degeneration. After 2 days in vitro, its originally well-organized structure 
was strongly disorganized while the upper tissue seemed to grow properly. Generally, 
the outer half of the upper tissue, including the ONL, the OPL and the outer margin of 
the INL, showed nearly well-preserved structures. But in the immunostainings for 
PKCα, calretinin, and NOS (Figure 3.2.2 - 3.2.4, Chapter 3.2), signs of degeneration 
were visible in the inner margin of the INL, the entire IPL and the GCL. Most 
obviously, the cells in the GCL had disappeared after about 2 days of cultivation 
(Figure 3.2.4, Chapter 3.2). As loss encompassed both soma and processes, strong 
structural disturbances in the IPL occured. Thus, in PKCα stainings (Figure 3.2.2, 
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Chapter 3.2), there were discrete gaps in the layer of the rod bipolar cell axon terminal 
systems.  
In flattened cultures, the degeneration started from the photoreceptors, which were 
attached to the membrane. Under such circumstances, the ONL, the OPL, and the 
outer margin of the INL were most strongly affected by degeneration. Because of the 
continuous loss of photoreceptors, the ONL became thinner and thinner during 
cultivation (Figure 3.2.1, Chapter 3.2). Therefore, the postsynaptic neurons were also 
affected due to missing presynaptic partners. The entire OPL displayed a wave-like 
shape and some horizontal cell somata misplaced to the ONL were observed (Figure 
3.2.3, Chapter 3.2). In addition, when the cultivation was in progress, a substantial 
number of rod bipolar cell somata moved towards the inner margin of the INL while 
more and more gaps were found in-between existing somata, indicating rod bipolar 
cell loss.  
Other groups grew similar flattened whole-mount cultures of mouse retina obtained 
on embryonic day 15 ~ 17 for about 18 days (Tomita et al., 1996; Hatakeyama et al., 
2001). Caffe and his co-workers were able to culture flattened mouse retina of P2 for 
26 days using a very sophisticated serum-free medium (Caffe et al., 2001). It seems 
that the components of the medium play a big role in culturing young retina for a 
longer time. Nevertheless, the time frame for preserving retinal explants in my study 
was sufficient to perform the transduction and allow for gene expression.   
4.2.2 Dissociated retinal cell culture 
Cells dissociated from mouse retina could be cultured for more than 4 weeks in my 
study. Cells were prepared from animals of P2 to P4. When cells were obtained from 
mice older than P4, they could not be cultured for more than 2 days. For dissociated 
retinal cell cultures, laminin-coated coverslips and serum-containing medium were 
necessary. With the laminin coating, dissociated cells settled on the coverslips much 
faster, which greatly increased the survival rate. In addition, neurites were grown 
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earlier on laminin-coated coverslips than on coverslips without coating, in agreement 
with a previous report that laminin promotes neuritic regeneration of cultured neurons 
(Manthorpe et al., 1983). Based on my observation, a good survival rate of mouse 
retinal neurons is strongly related to cell-cell interactions. The earlier neurites grow 
out, the earlier neurons can interact with each other and, thus, the more cells can 
survive in vitro. Besides, the presence of glia cells was found to promote survival of 
cultured neurons. During very preliminary experiments, I attempted to grow glia free 
cultures by using serum free medium (serum-free DMEM or serum-free Neurobasal 
medium (Gibco)) in order to obtain pure neuronal cultures. In these cultures, neurons 
died rapidly within two to four days of cultivation while glia cells vanished. It was 
reported that rat retinal cells can be cultured in serum-free medium (Gomes and 
Cayouette, 2010). However, the same group pointed out that under these conditions 
cell survival is drastically decreased for mouse retinal cells. Most likely, the glia cells 
form a supporting cell layer on which neurons grow or they also secrete factors that 
are essential for mouse retinal neurons to survive.  
Identification of cell types is an important issue in dissociated cultures. In this kind of 
culture the environment is totally different from that of native tissue. For example, 
Syt2-immunoreactive type 6 bipolar cells most notably changed to multipolar-like 
morphology (Figure 3.2.8, Chapter 3.2). Nevertheless, nearly all main cell types, 
except for ganglion cells could be identified based on cell type specific 
immunostaining and morphological parameters, i.e. soma size or neurite length. In 
addition, quite a number of cells were found to express sGC in the cultures and they 
showed cGMP-IR after the stimulation with NO donors (Figure 3.5.2, Chapter 3.5). 
 
4.3 AAV-mediated transduction 
To express foreign proteins like Cygnet-2.1, the cDNA encoding the protein has to be 
introduced into the target cells. In this thesis, two gene delivery approaches have been 
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used: lipofectamine-mediated transfection and AAV-mediated transduction. Both 
methods worked well in HEK-293 cells. However, it was much more difficult to 
introduce genes into retinal neurons. In this case, AAV-mediated transduction was 
more efficient than lipofectamine-induced transfection (data not shown). AAVs are 
also suited to transduce cells in vivo. Hence, AAVs are promising candidates for 
delivering gene cargos into cells both in vitro and in vivo.  
4.3.1 AAV-mediated transduction in vitro 
During my studies, seven different serotypes of AAVs were tested and they all 
successfully transduced retinal cells in vitro. Except for AAV5 that displayed an 
extremely low transduction efficiency, the remaining six serotypes of AAVs (AAV1, 
AAV2, AAV4, AAV6, AAV8, and AAV9) were further applied for characterization of 
AAV-mediated transduction both in vitro and in vivo, displaying serotype-dependent 
transduction patterns.  
In dissociated retinal cultures, the number of viral particles per seeded cell could be 
easily adjusted. Moreover, in this kind of culture the access of the viruses to the 
cultured cells was optimal. The percentage of transduced cells in dissociated cultures 
was on average less than 10%. However, it should be kept in mind that the cultures 
comprised several cell types. As each AAV serotype may target certain cell types 
preferentially, the transduction efficiency should be determined for each cell type. 
Table 3.3.1 (Chapter 3.3.1) summarizes the transduction efficiency of different 
serotypes for identified cell types. AAV2 could infect all identified cell types and 
showed the highest efficiency. AAV6 also could infect all types listed in the table, but 
showed lower efficiency in each group than AAV2. The remaining AAV serotypes 
showed certain selectivity for different cell types. For example, AAV1 targeted 
glycinergic cells better than GABAergic or NOS-positive amacrine cells. Roughly 30% 
of the glycinergic cells were transfected. However, glycinergic cells comprise several 
subtypes in the mouse retina (Pourcho and Goebel, 1985; Menger et al., 1998; 
Radhakrishnan, 2009). It could be that each of the different glycinergic cell 
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populations is transduced with a similar efficiency of around 30%. On the other hand, 
certain glycinergic cell types might be transduced with higher efficiency while other 
cell types might not be transduced at all, yielding an average transduction rate of 30%. 
AAV4 seemed to mainly target photoreceptors (identified by recoverin-IR and soma 
size) with about 8% efficiency, which is close to the efficiency of AAV2, but did not 
target amacrine cells at all. If one would like to focus on photoreceptors and minimize 
expression of sensors or other optogenetic tools in other cell types, AAV4 might be a 
promising candidate. AAV8 and AAV9 were similar to each other, except that AAV8 
had nearly two fold higher efficiency for CaBP-positive cells than AAV9. However, it 
should be noted that the immunomarkers listed in the table usually stain more than 
one cell type - except for CaBP that is predominantly found in horizontal cells and to 
a much lesser extent in certain amacrine cells. If it was desirable to determine 
transduction efficiency in the different retinal cell types in more detail, more 
counterstainings with a greater variety of cell-specific markers would be necessary. 
In whole-mount cultures transduced by AAVs, GFP expression was predominantly 
found in Müller cells. For most retinal cell types, accessibility is strongly reduced in 
the whole-mounted retina. Müller cells on the other hand span the entire retina and 
extend large endfeet to the retinal borders, making them more accessible. Very similar 
results for AAV1, 2, and 5 were reported in whole-mount retinal explants from P7 
mice (Pang et al., 2008). In addition, AAV2 was the most efficient serotype in their 
studies, which agrees with my findings. In general, the authors reported higher 
transduction efficiency than was observed in my study. This might be related to the 
longer incubation time of the explants with the viruses (30 minutes in their studies, 15 
minutes in mine). In my studies, however, the incubation time was limited to 15 
minutes as explants were nearly dried out after 15 minutes of incubation with virus in 
the absence of medium.  
4.3.2 AAV-mediated transduction in vivo 
Surprisingly, transduction in vivo yielded infection patterns that differed from those 
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observed in vitro. Generally, the transduction efficiency was lower in vivo than in 
dissociated cultures. This is most probably an effect of the reduced accessibility of 
retinal cells in the intact retina. Often, at sites with higher GFP expression the retinal 
structures were found to be disturbed. Most likely, the retina was damaged during the 
injection which enhanced the accessibility for the viruses. AAV2 was found to 
efficiently transduce many cells in the middle layers of the retina even at sites where 
the retina was intact. Some of AAV2-infected cells (including cone bipolar cells and 
amacrine cells) in the INL were also sGC-immunoreactive, a prerequisite for the 
investigation of cGMP metabolism controlled by NO with Cygnet-2.1.  
As judged from vertical sections of retinae transduced in vivo in my study, AAV2 
infected photoreceptors, bipolar cells, amacrine cells, ganglion cells, and Müller cells. 
The transduction patterns were not fully identical to those of previous studies by other 
groups (Table 4.1). There are three parameters that mainly differ between the studies: 
animal age, promoter for vectors and position of injection (intravitreal or subretinal).  
Table 4.1: Transduction pattern of AAV2 in native mouse retina. 
Mouse Promoter Position Transduction Pattern References 
P7 CBA* 
intravitreal ganglion cells, Müller cells 
(Pang et al., 2008) 
subretinal photoreceptors 
Adult CMV 
intravitreal 
amacrine cells, ganglion 
cells, Müller cells 
(Auricchio et al., 
2001) 
subretinal photoreceptors 
P0 CAG** subretinal 
horizontal cells, amacrine 
cells, ganglion cells 
(Watanabe et al., 
2013) 
Adult CAG subretinal 
photoreceptors, horizontal 
cells, ganglion cells 
(Charbel Issa et 
al., 2013) 
P5 CMV 
intravitreal 
/ 
subretinal 
photoreceptors, bipolar cells, 
amacrine cells, ganglion 
cells, Müller cells 
(my data) 
* CBA: chicken β-actin promoter 
** CAG: CMV-actin-globin hybrid promoter 
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During my ocular injections, I found it difficult to determine the exact position of the 
needle as the optics of the eye is blurry in young animals. From earlier reports 
(Auricchio et al., 2001; Pang et al., 2008), subretinal injection yielded photoreceptor 
transduction while intravitreal injection lead to transduction of inner retinal cells. In 
the other two papers (Charbel Issa et al., 2013; Watanabe et al., 2013), this difference 
was not observed. This would mean that even with subretinal administration, the 
viruses could cross the entire thickness of the retina and infect cells in all layers. 
Although the injection position was not exactly determined in my experiments, using 
AAV2 I found transduction throughout the entire thickness of the retina.  
Promoters may also influence the transduction pattern. Actually, there is not a 
promoter that can target all types of retinal neurons. On the other hand, during most 
applications, not all cell types need to be targeted. Theoretically, using a cell type 
specific promoter can restrict the transgene expression to the desired cells. As an 
extension of this project in the future, one could try to exclusively transduce 
sGC-immunoreactive cells with AAV2 expressing Cygnet-2.1 under the control of an 
sGC promoter.  
In this thesis, for several reasons in vivo transduction was established in newborn 
mice. In such young mice, the retinal limiting membranes are supposed to be less well 
developed and, therefore, hinder virus diffusion to a lesser extent than in adult retina. 
In addition, performing transduction in young mice can save time for expression. 
Once the mice become adult, their retinae can be used for imaging experiments as 
sensor expression is complete. Apart from AAV mediated transduction, 
electroporation is another method to deliver cDNA encoding optogenetic sensors to 
cells. In this case, cDNA is applied in form of plasmids. Since electroporation works 
more efficient for mitotic cells than postmitotic cells, DNA injection and 
electroporation must be performed in newborn mice (Venkatesh et al., 2013). 
However, there seem to be unexpected disadvantages when performing ocular 
injections in young animals. In my studies retinal folds and disturbed layering were 
consistently found after the injection. The mechanical damage was most probably 
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caused during the injection process. Young mice have very soft retinae that can be 
easily affected by pressure changes in the small eye ball or by accidental contact with 
the injection needle. Adult mice have larger eyes that might be less sensitive to 
mechanical damage. Moreover, adult mouse eyes provide clear vision through the 
pupil. With the help of appropriate optical tools, it is possible to locate the exact 
position of the injection needle: subretinal or intravitreal. Numerous publications have 
shown that it is possible to transduce neurons in the adult mouse retina (Auricchio et 
al., 2001; Yang et al., 2002; Lei et al., 2009; Park et al., 2009; Giove et al., 2010; Lei 
et al., 2010; Charbel Issa et al., 2013; Kay et al., 2013; Birke et al., 2014; Trapani et 
al., 2014). Therefore, in future studies it should be considered to perform ocular 
injection in adult mouse, rather in young animals.   
Vertical sections of transduced retinae revealed a certain degree of tropism for each 
AAV serotype. AAV1 targeted photoreceptors and Müller cells with low efficiency 
(Figure 3.4.1, Chapter 3.4.1). Very similar results were reported in adult mouse retina 
using AAV1 and the same CMV promoter (Auricchio et al., 2001). When AAV1 was 
used with the CBA promoter, transduction showed even lower efficiency and was 
restricted to Müller cells (Pang et al., 2008). In contrast, AAV1 in conjunction with 
the CAG promoter showed very high transduction efficiency in photoreceptors, 
horizontal cells, and Müller cells after subretinal administration in P0 mice (Watanabe 
et al., 2013). For AAV4, GFP expression was found nearly only in photoreceptors in 
my data (Figure 3.4.1, Chapter 3.4.1). No report on AAV4 transduction in the retina 
was found in the literature. When AAV6 was used with the CMV promoter in the 
adult mouse retina (Yang et al., 2002) or with the CAG promoter in rat retina 
(Klimczak et al., 2009), no retinal neurons were transduced, but retinal pigment 
epithelium cells, which fits to my data (Figure 3.4.1, Chapter 3.4.1). The stark 
difference in the expression patterns observed with AAV6 in vitro and in vivo cannot 
be explained. Nevertheless, it seems that AAV6 is not suitable for transducing retinal 
cells in vivo. The transduction efficiency of AAV8 seems to be low (Park et al., 2009). 
Again, using the CAG promoter instead of the CMV promoter could increase the 
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transduction efficiency (Watanabe et al., 2013). AAV9 in conjunction with the CMV 
promoter strongly infected photoreceptors and Müller cells following subretinal 
injection (Lei et al., 2009). Again in Watanabe’s studies, AAV9 using the CAG 
promoter could target more cell types: photoreceptors, horizontal cells, amacrine cells 
and ganglion cell, but no Müller cells (Watanabe et al., 2013). In summary, the use of 
the CAG promoter should be considered in future studies, as it might yield better 
expression.  
 
4.4 Cygnet-2.1 expression upon AAV-mediated transduction 
Using antibodies against cGMP, I could show that the intracellular cGMP 
concentration in cultured sGC-positive retinal cells can be greatly increased by NO 
stimulation (Figure 3.4.2., Chapter 3.4.2). Cygnet-2.1 sensors were successfully 
expressed in dissociated retinal cultures using lipofectamine transfection. Upon 
stimulation with an NO donor transfected retinal cells showed clear changes in the 
CFP/YFP ratio, indicating an increase in the internal cGMP concentration (Figure 
3.4.3, Chapter 3.4.2). Both results agree well and prove that dissociated retinal cell 
cultures can be used as an in vitro retina model to study the NO-cGMP pathway.  
Thereafter, AAVs were used to introduce Cygnet-2.1 into cultured retinal cells. Upon 
transduction, more than 100 cells/coverslip showed fluorescence (compared to 2 - 5 
cells/coverslip in the cultures that were transfected using lipofectamine). Hence, 
transduction efficiency was much higher than transfection efficiency. Surprisingly and 
most unfortunately however, it seems as if Cygnet-2.1 was not functional upon 
AAV-mediated transduction. This holds true for expression in retinal neurons in which 
cGMP synthesis was stimulated with NO (Figure 3.4.4, Chapter 3.4.3) and for FlpTS 
GC-A cells that were stimulated with ANP (Figure 3.4.6, Chapter 3.4.3).  
Why is Cygnet-2.1 not functional when expressed using AAVs? In order to generate 
AAVs, Cygnet-2.1 had to be cloned into an appropriate plasmid. Using this plasmid 
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for lipofectamine transfection yielded functional sensors. Hence, the problem does not 
lie in the DNA sequence but seems to originate in the packaging of DNA into AAVs 
or in the expression of sensor protein from the packed and virally transduced (but not 
from the transfected) DNA in the infected cell.  
Most probably, the DNA encoding Cygnet-2.1 was not correctly packed into the viral 
capsid. Native AAVs contain a single-stranded DNA that is about 4.7 kilobases long. 
In the viruses used in this thesis, the transgene was incorporated in a 
self-complementary form to increase the speed of expression. Thus, the effective 
length of the DNA was shortened to 50% (about 2350 bp). The CMV promoter (630 
bp) plus Cygnet-2.1 (3200 bp) occupy 3830 bp. Probably, this caused problems in 
packaging the DNA into the viral capsid. How this results in nonfunctional sensors, is 
not entirely clear. One might assume that the DNA strand is fragmented during 
packaging. On the other hand, both CFP and YFP fluorescence could be detected upon 
transduction. As YFP is located at the C-terminus of the sensor, YFP fluorescence can 
theoretically only be expected if the total cDNA – from the promoter to the 3’ end - 
has been transcribed. At present it can only be speculated how the DNA might be 
affected during the packing process to yield non-functional sensors. 
A similar situation was observed in the case of the FRET-based cAMP sensor Epac1 
in our lab. The Epac1 protein is of similar size as Cygnet-2.1. Again, Epac1 was not 
functional if expressed via AAV mediated transduction. Preliminary experiments 
suggest that using the DNA in the single-stranded rather than in the 
self-complementary form may yield functional Epac1 upon AAV mediated 
transduction (Nadine Gruteser, ICS-4, personal communication). If these results can 
be confirmed, it is suggested to also express Cygnet-2.1 using the single-stranded 
rather than the self-complimentary form.  
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4.5 Outlook 
In this thesis, the genetically encoded cGMP sensor Cygnet-2.1 has been 
characterized in the cell model FlpTS GC-A. Retinal cultures were established as in 
vitro retina models. The metabolism of the second messenger cGMP was 
spatiotemporally monitored in retinal cultures, which principally proves the feasibility 
of using Cygnet-2.1 to study the NO-cGMP pathway in the mouse retina. Moreover, 
AAV-mediated transduction was established in vitro in retinal cultures as well as in 
vivo using ocular injections. Unfortunately, upon AAV-mediated Cygnet-2.1 
expression no responses to cGMP synthesis could be detected. However, the problem 
might be solved by using single-stranded rather than self-complementary DNA. 
Alternatively, cDNA coding for Cygnet-2.1 might be introduced into retinal cells 
using the electroporation method (Matsuda and Cepko, 2004, 2007; Lagali et al., 
2008). Once functional Cygnet-2.1 sensors can be expressed in retinal neurons in vivo, 
the investigation of cGMP metabolism by NO modulation could be conducted in a 
straightforward way. 
In addition, the techniques that were established in this thesis like ocular injection, in 
vitro retinal models and AAV approaches can be used for many other applications. For 
example, in the retina cAMP metabolism and its modulation remains mysterious as 
well. Thus, the cAMP sensor Epac1 could be employed to study cAMP metabolism 
using these established platforms. Taken together, the present study has established 
several methods that are very useful in many aspects of retinal research.  
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